[
  {
    "date": "2023-12-30",
    "symbol": "PHAR",
    "period": "FY",
    "documenttype": "20-F",
    "documentregistrationstatement": "false",
    "documentannualreport": "true",
    "documentperiodenddate": "2023-12-31",
    "currentfiscalyearenddate": "--12-31",
    "documenttransitionreport": "false",
    "documentshellcompanyreport": "false",
    "entityfilenumber": "001-39822",
    "entityregistrantname": "Pharming Group N.V.",
    "entityincorporationstatecountrycode": "P7",
    "entityaddressaddressline1": "Darwinweg 24",
    "entityaddresspostalzipcode": "2333 CR",
    "entityaddresscityortown": "Leiden",
    "entityaddresscountry": "NL",
    "contactpersonnelname": "Dr. Sijmen de Vries",
    "countryregion": 31,
    "cityareacode": 71,
    "localphonenumber": "5247 400",
    "security12btitle": "American Depositary Shares, each representing ten ordinary shares, nominal value EUR 0.01 per share",
    "tradingsymbol": "PHAR",
    "securityexchangename": "NASDAQ",
    "entitycommonstocksharesoutstanding": 671073243,
    "entitywellknownseasonedissuer": "Yes",
    "entityvoluntaryfilers": "No",
    "entitycurrentreportingstatus": "Yes",
    "entityinteractivedatacurrent": "Yes",
    "entityfilercategory": "Large Accelerated Filer",
    "entityemerginggrowthcompany": "false",
    "icfrauditorattestationflag": "true",
    "documentfinstmterrorcorrectionflag": "false",
    "documentaccountingstandard": "International Financial Reporting Standards",
    "entityshellcompany": "false",
    "entitycentralindexkey": 1828316,
    "documentfiscalyearfocus": 2023,
    "documentfiscalperiodfocus": "FY",
    "amendmentflag": "false",
    "auditorfirmid": 1243,
    "auditorname": "Deloitte Accountants B.V.",
    "auditorlocation": "Amsterdam, The Netherlands",
    "revenuefromcontractswithcustomers": 245316000,
    "costofsales": 25212000,
    "grossprofit": 220104000,
    "otherincome": 23349000,
    "researchanddevelopmentexpense": 68914000,
    "generalandadministrativeexpense": 55877000,
    "salesandmarketingexpense": 124049000,
    "operatingexpenseexcludingcostofsales": 248840000,
    "profitlossfromoperatingactivities": -5387000,
    "gainslossesonchangeinfairvalueofderivatives": -930000,
    "otherfinanceincome": 3663000,
    "otherfinancecost": 9069000,
    "financeincomecost": -6336000,
    "shareofprofitlossofassociatesandjointventuresaccountedforusingequitymethod": -289000,
    "profitlossbeforetax": -12012000,
    "incometaxexpensecontinuingoperations": -1464000,
    "profitloss": -10548000,
    "basicearningslosspershare": -0.016,
    "dilutedearningslosspershare": -0.016,
    "othercomprehensiveincomenetoftaxexchangedifferencesontranslation": 5936000,
    "othercomprehensiveincomethatwillbereclassifiedtoprofitorlossnetoftax": 5936000,
    "othercomprehensiveincomenetoftaxfinancialassetsmeasuredatfairvaluethroughothercomprehensiveincome": 1167000,
    "othercomprehensiveincomethatwillnotbereclassifiedtoprofitorlossnetoftax": 1167000,
    "othercomprehensiveincome": 7103000,
    "comprehensiveincome": -3445000,
    "intangibleassetsotherthangoodwill": 71267000,
    "propertyplantandequipment": 9689000,
    "rightofuseassets": 23777000,
    "noncurrentprepayments": 92000,
    "deferredtaxliabilityasset": -29761000,
    "investmentsinassociatesaccountedforusingequitymethod": 2285000,
    "noncurrentinvestmentsinequityinstrumentsdesignatedatfairvaluethroughothercomprehensiveincome": 2020000,
    "noncurrentfinancialassetsatfairvaluethroughprofitorloss": 6093000,
    "noncurrentrestrictedcashandcashequivalents": 1528000,
    "noncurrentassets": 146512000,
    "inventories": 56760000,
    "tradeandothercurrentreceivables": 46158000,
    "currentfinancialassetsheldtomaturity": 151683000,
    "cashandcashequivalents": 61741000,
    "currentassets": 316342000,
    "assets": 462854000,
    "issuedcapital": 7669000,
    "sharepremium": 478431000,
    "otherreserves": -2057000,
    "retainedearnings": -265262000,
    "equity": 218781000,
    "noncurrentportionofnoncurrentbondsissued": 136598000,
    "noncurrentleaseliabilities": 29507000,
    "noncurrentliabilities": 166105000,
    "currentbondsissuedandcurrentportionofnoncurrentbondsissued": 1824000,
    "tradeandothercurrentpayables": 72528000,
    "currentleaseliabilities": 3616000,
    "currentliabilities": 77968000,
    "equityandliabilities": 462854000,
    "increasedecreasethroughtransfertostatutoryreserve": -423000,
    "decreaseincreasethroughtaxonsharebasedpaymenttransactions": -204000,
    "increasedecreasethroughsharebasedpaymenttransactions": 9251000,
    "increasedecreasethroughexerciseofoptions": 160000,
    "increasedecreasethroughtransactionswithowners": 160000,
    "adjustmentsfordepreciationandamortisationexpenseandimpairmentlossreversalofimpairmentlossrecognisedinprofitorloss": 15925000,
    "adjustmentsforsharebasedpayments": 9251000,
    "adjustmentsforgainslossesonchangeinfairvalueofderivatives": -930000,
    "gainondisposalfrompriorityreviewvouchersale": 21279000,
    "adjustmentsforfinanceincome": 3663000,
    "adjustmentsforfinancecosts": 9069000,
    "adjustmentsforundistributedprofitsofinvestmentsaccountedforusingequitymethod": -289000,
    "otheradjustmentstoreconcileprofitloss": -1079000,
    "cashflowsfromusedinoperationsbeforechangesinworkingcapital": -2569000,
    "adjustmentsfordecreaseincreaseininventories": -14434000,
    "adjustmentsfordecreaseincreaseintradeandotherreceivables": -18539000,
    "adjustmentsforincreasedecreaseintradeandotherpayables": 16228000,
    "cashflowsfromusedindecreaseincreaseinrestrictedcashandcashequivalentsoperatingactivities": -216000,
    "increasedecreaseinworkingcapital": 16961000,
    "interestreceivedclassifiedasoperatingactivities": 2883000,
    "incometaxespaidrefundclassifiedasoperatingactivities": 655000,
    "cashflowsfromusedinoperatingactivities": -17302000,
    "purchaseofpropertyplantandequipmentclassifiedasinvestingactivities": 1437000,
    "proceedsfrompriorityreviewvouchersale": 21279000,
    "purchaseofintangibleassetsexcludinglicensesclassifiedasinvestingactivities": 27000,
    "proceedsfromsalesofinterestsinassociates": 7300000,
    "purchaseofheldtomaturityfinancialassets": 382014000,
    "proceedsfromdisposalormaturityofheldtomaturityfinancialassets": 232811000,
    "cashflowsfromusedininvestingactivities": -129388000,
    "paymentsofleaseliabilitiesclassifiedasfinancingactivities": 5126000,
    "interestpaidclassifiedasfinancingactivities": 4046000,
    "proceedsfromissuingotherequityinstruments": 8133000,
    "cashflowsfromusedinfinancingactivities": -1039000,
    "increasedecreaseincashandcashequivalentsbeforeeffectofexchangeratechanges": -147729000,
    "effectofexchangeratechangesoncashandcashequivalents": 2128000,
    "disclosureofcorporateinformationtextblock": "CORPORATE INFORMATION",
    "marketablesecuritiestextblock": "MARKETABLE SECURITIES",
    "descriptionofaccountingpolicyfornewaccountingpronouncementspolicytextblock": "New and revised IFRS standards",
    "descriptionofaccountingpolicyforbasisofconsolidationpolicytextblock": "Basis of consolidation",
    "descriptionofaccountingpolicyregardingdistinctionbetweencurrentandnoncurrentpolicytextblock": "Distinction between current and non-currentAn item is classified as current when it is expected to be realized (settled) within 12 months after the end of the reporting year. Liabilities are classified as current liabilities unless the Group has an unconditional right to defer settlement of the liability for at least 12 months after the end of the reporting year.",
    "descriptionofaccountingpolicyforuseofjudgementsestimatesandassumptionspolicytextblock": "Material accounting judgements and estimates",
    "scheduleofotherincometabletextblock": "Amounts in $ ‘000202320222021Grants1,784 1,774 2,620 Gain on divestment in associates— 12,242 — Proceeds from PRV sale21,279 — — Other286 507 — Total23,349 14,523 2,620",
    "disclosureofcostofsalesexplanatorytabletextblock": "Costs of sales in 2023, 2022 and 2021 were as follows:Amounts in $ ‘000202320222021Cost of inventories recognized as expenses(21,404)(17,398)(19,107)Royalty fees(2,145)— — Obsolete inventory impairments(1,663)(164)(2,035)Total(25,212)(17,562)(21,142)",
    "disclosureofresearchanddevelopmentexpensetabletextblock": "Research and development costs in 2023, 2022 and 2021 were as follows:Amounts in $ ‘000202320222021Employee costs(26,830)(20,595)(24,451)Amortization costs intangible assets(218)(55)(132)Impairment losses intangible assets(253)— (4,992)Depreciation Property, plant and equipment and right of use assets(1,636)(1,602)(3,152)Direct Operating Expenses(36,226)(27,107)(33,190)Other indirect research and development costs(3,751)(3,172)(4,452)Total research and development costs(68,914)(52,531)(70,369)",
    "disclosureofmarketingandsalescoststabletextblock": "Marketing and sales costs for 2023, 2022 and 2021 were as follows:Amounts in $ ‘000202320222021Employee costs(44,478)(32,858)(24,125)Amortization costs intangible assets(4,985)(3,765)(4,098)Depreciation PPE and right of use assets(403)(372)(930)Direct Operating Expenses(67,366)(42,398)(28,543)Other indirect marketing and sales costs(6,817)(6,410)(1,749)Total marketing and sales costs(124,049)(85,803)(59,445)",
    "disclosureofemployeebenefitsexplanatorytabletextblock": "Employee benefit costs for 2023, 2022 and 2021 were as follows:Amounts in $ ‘000202320222021Salaries(71,690)(53,328)(44,202)Social security costs(8,604)(6,317)(5,318)Pension costs(2,980)(2,284)(2,179)Share-based compensation(9,251)(6,392)(9,055)Total(92,525)(68,321)(60,754)",
    "disclosureofdetailedinformationaboutdepreciationandamortizationexpenseexplanatorytabletextblock": "Depreciation and amortization charges are included in:Amounts in $ ‘000202320222021Property, plant and equipment (1,494)(1,993)(2,158)Intangible assets(5,852)(4,312)(4,232)Total(7,346)(6,305)(6,390)Right of use assets(3,664)(2,565)(2,781)Total(3,664)(2,565)(2,781)",
    "disclosureoffinanceincomecostexplanatorytabletextblock": "Amounts in $ ‘000202320222021Interest income3,663 85 53 Foreign currency gains— 4,400 14,841 Other financial income3,663 4,485 14,894 Foreign currency losses(2,971)— — Interest loans and borrowings(4,876)(4,736)(5,296)Interest leases(1,088)(622)(795)Other financial expenses(134)(105)(94)Other financial expenses(9,069)(5,463)(6,185)Total other financial income and expenses(5,406)(978)8,709",
    "disclosureofreconciliationofaccountingprofitmultipliedbyapplicabletaxratetabletextblock": "The following table reconciles the tax credit (expense) at the statutory rate to actual credit (expense) for the year in the consolidated income statement:",
    "scheduleofbalancesofnetdeferredtaxassetsliabilitiestabletextblock": "The balance of the net deferred tax assets/(liabilities) is therefore shown below:Amounts in $ ‘00020232022Total deferred tax assets37,863 29,211 Total deferred tax liabilities(8,102)(6,238)Total net deferred tax assets /(liabilities)29,761 22,973",
    "disclosureofrestrictedcashandcashequivalentsexplanatorytabletextblock": "Amounts in $ ‘00020232022Restricted cash (non-current)1,528 1,099 Restricted cash (current)— 213 Cash and cash equivalents61,741 207,342 Total restricted cash, cash and cash equivalents63,269 208,654",
    "disclosureofinventoriesexplanatorytabletextblock": "Amounts in $ ‘00020232022Finished goods 18,349 12,460 Work in progress 37,706 29,553 Raw materials705 313 Balance at December 3156,760 42,326",
    "disclosureofchangesintheadjustmenttonetrealisablevalueofinventoryexplanatorytabletextblock": "Changes in the adjustment to net realizable value:Amounts in $ ‘00020232022Balance at January 1(1,971)(2,448)Addition to impairment(3,878)(164)Release of impairment— 312 Usage of impairment1,673 195 Currency translation(100)134 Balance at December 31(4,276)(1,971)",
    "disclosureoftradeandotherreceivablesexplanatorytabletextblock": "Amounts in $ ‘00020232022Trade receivables35,408 20,964 Prepaid expenses3,543 2,288 Value added tax3,804 1,453 Other receivables2,145 1,117 Taxes and social securities1,258 1,797 Balance at December 3146,158 27,619",
    "disclosureofmovementsofborrowingstabletextblock": "Recognition and movements of the convertible bonds were as follows:Amounts in $ ‘00020232022Balance at January 1133,386 140,886 Interest paid (cash flow)(4,046)(3,952)Amortization transaction cost830 784 Accrued interest4,046 3,952 Currency translation4,206 (8,284)Balance at December 31138,422 133,386 - Current portion1,824 1,768 - Non-current portion136,598 131,618",
    "disclosureofquantitativeinformationaboutleasesforlesseetabletextblock": "Lease liabilities can be specified as follows: Amounts in $ ‘00020232022Balance at January 133,308 20,875 Additions1,295 15,822 Remeasurement1,865 426 Interest expense accrued1,193 718 Payments of lease liabilities(5,126)(3,311)Other movements(319)(348)Currency translation907 (874)Balance at December 3133,123 33,308 - Current portion3,616 3,465 - Non-current portion29,507 29,843",
    "scheduleoftradeandotherpayablestabletextblock": "Trade and other payables as at December 31, 2023 and 2022 are as follows:",
    "scheduleofthresholdsandpayoutpercentagesforlongtermincentiveprogramtabletextblock": "The thresholds and payout percentages for the LTI program are given by the following table, as to be determined for each of the AScX and IBB indices separately (each weighted at   of pay-out):TSR equal to index80%pay-outTSR 10% above index90% pay-outTSR 20% above index100% pay-outTSR 40% above index110% pay-outTSR 60% above index120% pay-outTSR 80% above index130% pay-outTSR 100% above index150% pay-outTSR below index0% pay-out",
    "scheduleofmetricsusedforthetransitionarrangementfortheceotabletextblock": "The performance on both the TSR and the strategic corporate objectives, applying the respective weightings, led to the following vesting level under the One-Off Transition Arrangement for the CEO (i.e., second annual tranche of 1,400,000 shares):",
    "scheduleofmembersoftheboardofdirectorstabletextblock": "The Board of Directors has the following members:Dr. R. PetersChair of the Board of Directors and Non-Executive Board MemberAppointed September 25, 2023Ms. D. JornVice Chair of the Board of Directors and Non-Executive Board MemberMs. B. YanniNon-Executive Board MemberDr. M. PykettNon-Executive Board MemberMs. J. van der MeijsNon-Executive Board MemberMr. L. KruimerNon-Executive Board MemberMr. S. BaertNon-Executive Board MemberDr. S. de VriesExecutive Board Member and Chief Executive Officer",
    "scheduleofboardannualcompensationtabletextblock": "For 2023 the annual compensation of the non-executive members of the Board of Directors was as follows:",
    "disclosureofdetailedinformationaboutdirectorsremunerationexplanatorytabletextblock": "Compensation of the Non-Executive members of the Board of Directors and / or of former members of the Supervisory Board of Directors for 2023, 2022 and 2021 was as follows:",
    "disclosureofsharesheldbyrelatedpartiesexplanatorytabletextblock": "At December 31, 2023, the Non-Executive members of the Board of Directors held the following numbers of shares:Ordinary sharesDr. Richard Peters17,613Ms. Deborah Jorn127,714Ms. Barbara Yanni112,123Dr. Mark Pykett112,123Ms. Jabine van der Meijs87,285Mr. Leonard Kruimer87,285Mr. Steven Baert87,285Total631,428",
    "disclosureofmovementsofrelatedpartysharebasedpaymentarrangementsexplanatorytabletextblock": "The following table gives an overview of movements in number of option holdings of the individual members of the executive board of directors in 2023, the exercise prices and expiration dates up to December 31, 2023 (note that the exercise price in US$ is translated using 2023 closing exchange rate (1:1.1002)):January 1, 2023Granted 2023Exercised in 2023Forfeited/Expired in 2023December 31, 2023Exercise price ($)Expiration dateDr. Sijmen de Vries2,800,000 — — — 2,800,000 0.886 May 22, 2024",
    "disclosureofearningspershareexplanatorytabletextblock": "For the years ended December 31, 2023, 2022 and 2021, the basic and diluted profit per share are:",
    "numberofmarkets": 30,
    "cashandcashequivalentsandrestrictedcashandcashequivalentsandmarketablesecurities": 215000000,
    "closingforeignexchangerate": 1.1002,
    "averageforeignexchangerate": 1.079,
    "usefullifemeasuredasperiodoftimeintangibleassetsotherthangoodwill": "P10Y",
    "remainingamortisationperiodofintangibleassetsmaterialtoentity2019": "P13Y",
    "usefullifemeasuredasperiodoftimepropertyplantandequipment": "P10Y",
    "periodofservicebyemployeedefinedcontributionpension": "P6M",
    "employeeageeligiblefordefinedcontributionpension": "P18Y",
    "amountmatchedbyemployerdefinedcontributionpensionpercentage": 1,
    "employeecontributiondefinedcontributionpensionpercentage": 0.03,
    "vestingrequirementsforshareoptionsinsharebasedpaymentarrangementvestingperiod": "P5Y",
    "vestingrequirementsforsharebasedpaymentarrangementvestingperiod": "P3Y",
    "sharebasedpaymentarrangementserviceperiod": "P3Y",
    "performancerequirementsforsharebasedpaymentarrangementtotalshareholderreturnpercent": 0.4,
    "performancerequirementsforsharebasedpaymentarrangementlongtermstrategyorientedobjectivespercent": 0.6,
    "sharebasedpaymentarrangementperformanceperiod": "P3Y",
    "retentionrequirementforsharebasedpaymentarrangementretentionperiod": "P5Y",
    "numberofoperatingsegments": 4,
    "numberofreportablesegments": 4,
    "percentageofentitysrevenue": 0.83,
    "revenuefromgovernmentgrants": 1784000,
    "gainfrompriorityreviewvouchersaleproceeds": 21279000,
    "otherincomeother": 286000,
    "proportionofownershipinterestinassociate": 0.2298,
    "costofsalesexcludinginventorywritedown": 21404000,
    "royaltyexpense": 2145000,
    "inventorywritedownincludedincostofsales": 1663000,
    "researchanddevelopmentdirectoperatingexpenses": 36226000,
    "researchanddevelopmentemployeecosts": 26830000,
    "researchanddevelopmentamortizationcostsintangibleassets": 218000,
    "researchanddevelopmentimpairmentlossesintangibleassets": 253000,
    "researchanddevelopmentdepreciation": 1636000,
    "researchanddevelopmentotherindirectresearchanddevelopmentcosts": 3751000,
    "generalandadministrativeemployeecosts": 21216000,
    "generalandadministrativeamortisationcostsintangibleassets": 650000,
    "generalandadministrativedepreciationppe": 3118000,
    "generalandadministrativeimpairmentlossesofpropertyplantandequipment": 4663000,
    "generalandadministrativedirectoperatingexpenses": 11240000,
    "generalandadministrativeotherindirectgeneralandadministrativeexpense": 14990000,
    "marketingandsalesemployeecosts": 44478000,
    "marketingandsalesamortisationcostsintangibleassets": 4985000,
    "marketingandsalesdepreciation": 403000,
    "marketingandsalesdirectoperatingexpenses": 67366000,
    "marketingandsalesotherindirectmarketingandsalescosts": 6817000,
    "wagesandsalaries": 71690000,
    "socialsecuritycontributions": 8604000,
    "postemploymentbenefitexpensedefinedbenefitplans": 2980000,
    "expensefromsharebasedpaymenttransactionswithemployees": 9251000,
    "employeebenefitsexpense": 92525000,
    "depreciationandamortisationexpense": 1494000,
    "investmentincome": 3663000,
    "foreignexchangeloss": 2971000,
    "interestexpenseonborrowings": 4876000,
    "interestexpenseonleaseliabilities": 1088000,
    "financecosts": 134000,
    "otherfinanceincomecost": -5406000,
    "currenttaxexpenseincome": 5343000,
    "adjustmentsforcurrenttaxofpriorperiod": -241000,
    "currenttaxexpenseincomeandadjustmentsforcurrenttaxofpriorperiods": 5102000,
    "deferredtaxexpenseincomebeforeadjustments": -6639000,
    "adjustmentsfordeferredtaxofpriorperiods": 73000,
    "deferredtaxexpenseincometotal": -6566000,
    "accountingprofit": -12012000,
    "taxexpenseincomeatapplicabletaxrate": -3099000,
    "taxeffectofforeigntaxrates": -1123000,
    "taxeffectofincomeexpensefromtaxation": 6000,
    "taxeffectofexpensenotdeductibleindeterminingtaxableprofittaxloss": 266000,
    "taxeffectofsharebasedpayments": 2022000,
    "taxeffectadjustmentsofpriorperiod": 168000,
    "othertaxeffectsforreconciliationbetweenaccountingprofitandtaxexpenseincome": 644000,
    "deferredtaxassets": 37863000,
    "deferredtaxliabilities": 8102000,
    "deferredtaxexpenseincomerecognisedinprofitorloss": 7806000,
    "increasedecreasethroughotherchangesdeferredtaxliabilityasset": -19000,
    "deferredtaxrelatingtoitemschargedorcrediteddirectlytoequity": -457000,
    "deferredtaxassetrelatingtocurrencytranslation": 113000,
    "netdeferredtaxassetscurrent": 10500000,
    "deferredtaxliabilityrelatingtocurrencytranslation": 156000,
    "amortisationintangibleassetsotherthangoodwill": 3681000,
    "impairmentlossrecognisedinprofitorlossintangibleassetsotherthangoodwill": 253000,
    "acquisitionsthroughbusinesscombinationsintangibleassetsotherthangoodwill": 27000,
    "disposalsintangibleassetsotherthangoodwill": 253000,
    "increasedecreasethroughnetexchangedifferencesintangibleassetsotherthangoodwill": 18000,
    "changesinintangibleassetsotherthangoodwill": -250000,
    "additionsotherthanthroughbusinesscombinationspropertyplantandequipment": 32000,
    "increasedecreasethroughtransferspropertyplantandequipment": 6000,
    "increasedecreasethroughotherchangespropertyplantandequipment": 74000,
    "disposalspropertyplantandequipment": 14000,
    "depreciationpropertyplantandequipment": 365000,
    "depreciationpropertyplantandequipmentdisposals": 8000,
    "increasedecreasethroughnetexchangedifferencespropertyplantandequipment": 148000,
    "changesinpropertyplantandequipment": -268000,
    "depreciationexpense": 1500000,
    "additionstorightofuseassets": 1413000,
    "rightofuseassetsremeasurement": 1865000,
    "disposalsofrightofuseassets": 756000,
    "depreciationrightofuseassetsincludinginventory": 2913000,
    "depreciationrightofuseassetsdisposals": 700000,
    "rightofuseassetsimpairment": 4663000,
    "increasedecreasethroughnetexchangedifferencesrightofuseassets": 873000,
    "increasedecreaseinrightofuseassets": -5051000,
    "significantunobservableinputassets": 0.05,
    "depreciationrightofuseassetsinventory": 500000,
    "depreciationrightofuseassets": 3700000,
    "leasesremainingleaseterm": "P1Y",
    "rentalexpense": 4752000,
    "shareofprofitlossofassociatesaccountedforusingequitymethod": -289000,
    "investmentsaccountedforusingequitymethodcurrencytranslation": 73000,
    "gainslossesonfinancialassetsatfairvaluethroughprofitorloss": -930000,
    "noncurrentinvestmentsinequityinstrumentsdesignatedatfairvaluethroughprofitorlosscurrencytranslation": 196000,
    "percentageofordinarysharestradedatstockexchange": 0.995,
    "gainslossesonfinancialassetsmeasuredatfairvaluethroughothercomprehensiveincomenetoftax": 1573000,
    "noncurrentinvestmentsinequityinstrumentsdesignatedatfairvaluethroughothercomprehensiveincomecurrencytranslation": 44000,
    "currentfinancialassetsheldtomaturityaccruedinterest": 700000,
    "cashandcashequivalentsandrestrictedcashandcashequivalents": 63269000,
    "restrictedcashandcashequivalents": 1500000,
    "finishedgoods": 18349000,
    "workinprogress": 37706000,
    "rawmaterials": 705000,
    "inventorywritedown2011": 3878000,
    "inventoryusageofwritedownprovision": 1673000,
    "inventorycurrencytranslation": -100000,
    "currenttradereceivables": 35408000,
    "currentprepayments": 3543000,
    "currentvalueaddedtaxreceivables": 3804000,
    "othercurrentreceivables": 2145000,
    "currentreceivablesfromtaxesandsocialsecurities": 1258000,
    "borrowings": 138422000,
    "borrowingcostsrecognisedasexpense": 830000,
    "interestexpenseonborrowingsnotyetpaid": 4046000,
    "convertiblebondscurrencytranslation": 4206000,
    "currentborrowingsandcurrentportionofnoncurrentborrowings": 1824000,
    "longtermborrowings": 136598000,
    "leaseliabilities": 33123000,
    "increasethroughnewleasesliabilitiesarisingfromfinancingactivities": 1295000,
    "increasedecreasethroughremeasurementliabilitiesarisingfromfinancingactivities": 1865000,
    "increasedecreasethroughinterestexpenseliabilitiesarisingfromfinancingactivities": 1193000,
    "increasedecreasethroughfinancingcashflowsliabilitiesarisingfromfinancingactivities": -5126000,
    "leaseliabilitiesothermovements": -319000,
    "leaseliabilitiescurrencytranslation": 907000,
    "grossleaseliabilities": 5071000,
    "tradeandothercurrentpayablestotradesuppliers": 16022000,
    "currentpayablesonsocialsecurityandtaxesotherthanincometax": 6234000,
    "accrualsrebatesanddiscountscurrent": 16019000,
    "accrualsproductioncostscurrent": 11643000,
    "accrualsothercurrent": 6976000,
    "othercurrentpayables": 15634000,
    "sharebasedpaymentshareauthorizationperiodforissuance": "P18M",
    "expensefromsharebasedpaymenttransactionsinwhichgoodsorservicesreceiveddidnotqualifyforrecognitionasassets": 9300000,
    "numberofelementsusedinoptionpricingmodel": 6,
    "numberofminimumyearsoptionlife": "P3Y",
    "maximumgrantedoptionspercentageoverissuedandoutstandingshares": 0.1,
    "vestingrequirementsforsharebasedpaymentarrangementoptionsmaximumvestingperiod": "P5Y",
    "sharebasedpaymentarrangementoptionsminimumperiodtobedeemedlapsed": "P5Y",
    "descriptionofoptionlifeshareoptionsgranted": 1,
    "descriptionofexpectedvolatilityshareoptionsgranted": 0.38,
    "descriptionofriskfreeinterestrateshareoptionsgranted": 0.022,
    "sharebasedpaymentarrangementoptionsterminationofemploymentminimumperiodtobedeemedlapsed": "P1Y",
    "expectedvolatilityhistoricalendofmonthclosingsharepricesduration": "P3Y",
    "expectedcorrelationshistoricalcorrelationsbasedonendofmonthclosingquotesperiod": "P3Y",
    "sharebasedpaymentontargetvalueofsharestobeawardedpercentageofgrossannualsalary": 3,
    "sharebasedpaymentontargetvalueofsharestobeawardedpercentagebelowthelowestquartileofusbenchmarkgroup": 0.5,
    "sharebasedpaymentmaximumvalueofsharesthatcanvestunderprogrampercentageofgrossannualsalary": 4.5,
    "sharebasedpaymentexecutivedirectorsminimumretentionperiodofsharesawardedunderprogram": "P5Y",
    "sharebasedpaymentexecutivedirectorsvestingperiodaftergrantdate": "P5Y",
    "sharebasedpaymentexecutivedirectorsperformanceperiod": "P3Y",
    "sharebasedpaymentexecutivedirectorsminimumretentionperiodofsharesawardedunderprogramperiodaftervestingdate": "P2Y",
    "sharebasedpaymentexecutivedirectorsperformanceindicatortotalshareholderreturnpercentage": 0.4,
    "sharebasedpaymentexecutivedirectorsperformanceindicatorlongtermstrategyorientedobjectivespercentage": 0.6,
    "sharebasedpaymentexecutivedirectorstotalshareholderreturnoverindexpercentage": 0.1,
    "sharebasedpaymentexecutivedirectorspayoutpercentage": 0.8,
    "sharebasedpaymentarrangementotherequityinstrumentsexpectedvolatility": 0.42,
    "sharebasedpaymentarrangementotherequityinstrumentsriskfreeinterestrate": 0.0234,
    "sharebasedpaymentarrangementnumberofvestingtranches": 4,
    "numberofshareoptionsvestedinsharebasedpaymentarrangement": 9284834,
    "numberofoutstandingshareoptions": 34482312,
    "numberofshareoptionsexpiredinsharebasedpaymentarrangement": 205000,
    "numberofshareoptionsforfeitedinsharebasedpaymentarrangement": 1423375,
    "numberofshareoptionsgrantedinsharebasedpaymentarrangement": 270000,
    "numberofshareoptionsexercisedinsharebasedpaymentarrangement": 11756114,
    "numberofshareoptionsunvestedinsharebasedpaymentarrangement": 25197478,
    "weightedaverageexercisepriceofshareoptionsoutstandinginsharebasedpaymentarrangement2019": 0.952,
    "weightedaverageexercisepriceofshareoptionsexpiredinsharebasedpaymentarrangement2019": 0.847,
    "weightedaverageexercisepriceofshareoptionsforfeitedinsharebasedpaymentarrangement2019": 0.992,
    "weightedaverageexercisepriceofshareoptionsgrantedinsharebasedpaymentarrangement2019": 1.349,
    "weightedaverageexercisepriceofshareoptionsexercisedinsharebasedpaymentarrangement2019": 0.857,
    "weightedaverageexercisepriceofshareoptionsvestedinsharebasedpaymentarrangement": 0.856,
    "weightedaverageexercisepriceofshareoptionsunvestedinsharebasedpaymentarrangement": 0.987,
    "exercisepriceofoutstandingshareoptions2019": 0.28,
    "exercisevalueofshareoptionsoutstandinginsharebasedpaymentarrangement": 4967000000,
    "exercisepriceshareoptionsgranted2019": 0.223,
    "numberofinstrumentsotherequityinstrumentsgranted": 1681570,
    "weightedaverageexercisepriceofotherequityinstrumentsgrantedinsharebasedpaymentarrangement2019": 0.88,
    "numberofotherequityinstrumentsissuedinsharebasedpaymentarrangement": 1261595,
    "numberofotherequityinstrumentsforfeitedinsharebasedpaymentarrangement": 3708270,
    "numberofotherequityinstrumentsreservedinsharebasedpaymentarrangement": 5382913,
    "sharebasedpaymentexecutivedirectorsachievementlevelpercentage": 1.15,
    "sharebasedpaymentexecutivedirectorsweightinglevelpercentage": 0.4,
    "sharebasedpaymentexecutivedirectorsvestinglevelpercentage": 0.46,
    "keymanagementpersonnelcompensationbasesalary": 90000,
    "keymanagementpersonnelcompensationsharebasedpayment": 40000,
    "sharebasedpaymentsharevaluationvolumeweightedaveragepriceduration": "P20D",
    "keymanagementpersonnelcompensationadditionalcompensationamountperday": 1000,
    "directorsremunerationexpensebasesalary": 26000,
    "directorsremunerationexpensesharebasedpayment": 20000,
    "directorsremunerationexpense": 46000,
    "numberofsharesinentityheldbyrelatedparties": 17613,
    "keymanagementpersonnelcompensationshorttermemployeebenefits": 615000,
    "keymanagementpersonnelcompensationpostemploymentbenefits": 115000,
    "keymanagementpersonnelcompensationother": 35000,
    "keymanagementpersonnelcompensation": 2809000,
    "sharesreservedforissueunderoptionsandcontractsforsaleofshares": 1681570,
    "purchasesofgoodsrelatedpartytransactions": 4700000,
    "servicefeesreceivablerelatedpartytransactions": 1700000,
    "servicefeespayablerelatedpartytransactions": 500000,
    "contractualcapitalcommitments": 58300000,
    "collaborationandlicenseagreementmilestonepaymentsduringperiod": 10400000,
    "royaltyfeesovernetsalespercentage": 0.18,
    "royaltyfeesamountofnetsalestobeexceeded": 300000000,
    "royaltyfeespaymentterm": "P10Y",
    "royaltyfeesminimumroyaltyliabilitypercentage": 0.12,
    "royaltyfeesminimumroyaltyliabilityapplicablesaleslimit": 150000000,
    "cash": 172200000,
    "cashandcashequivalentsrestrictedcashaccountsreceivableandinventories": 84800000,
    "balancesdenominatedinothercurrency": 51100000,
    "sensitivityanalysisimpactoftenpercentstrengtheningofothercurrencyagainsttheusdollar": 5100000,
    "sensitivityanalysisimpactoftenpercentweakeningofothercurrencyagainsttheusdollar": -5100000,
    "tradeandotherpayablesundiscountedcashflows": 72528000,
    "bondsissuedundiscountedcashflows": 4126000,
    "derivativeandnonderivativefinancialliabilitiesundiscountedcashflows": 81725000,
    "financialassets": 63269000,
    "financialassetsatfairvalue": 63269000,
    "financialliabilities": 138422000,
    "financialliabilitiesatfairvalue": 138422000,
    "bankborrowingsundiscountedcashflows": 1824000,
    "undiscountedcontractualamountsdueincludingnominalinterest": 76530000,
    "liabilitiesarisingfromfinancingactivities": 138422000,
    "increasedecreasethroughobtainingorlosingcontrolofsubsidiariesorotherbusinessesliabilitiesarisingfromfinancingactivities": 1295000,
    "increasedecreasethroughamortizedcostsliabilitiesarisingfromfinancingactivities": 830000,
    "increasedecreasethroughotherchangesliabilitiesarisingfromfinancingactivities": 4206000,
    "weightedaverageshares": 657020521,
    "adjustedweightedaverageshares": 725463948,
    "numberofconvertiblebondsoutstanding": 62412622,
    "numberofsharesoutstandingdiluted": 671073243,
    "numberofrestrictedstockunitsoutstanding": 11187064,
    "numberofotherequityinstrumentsoutstandinginsharebasedpaymentarrangement": 17534261,
    "numberofsharesandotherinstrumentsoutstanding": 796689502,
    "numberofsharesauthorised": 1056000000,
    "authorizedsharecapital": 11600000,
    "parvaluepershare": 0.01,
    "numberofsharesoutstanding": 671073243,
    "increasedecreasethroughtransfertootherreserveequity": 6042000
  },
  {
    "date": "2022-12-31",
    "symbol": "PHAR",
    "period": "FY",
    "documenttype": "20-F",
    "documentregistrationstatement": "false",
    "documentannualreport": "true",
    "documentperiodenddate": "2022-12-31",
    "currentfiscalyearenddate": "--12-31",
    "documenttransitionreport": "false",
    "documentshellcompanyreport": "false",
    "entityfilenumber": "001-39822",
    "entityregistrantname": "Pharming Group N.V.",
    "entityincorporationstatecountrycode": "P7",
    "entityaddressaddressline1": "Darwinweg 24",
    "entityaddresspostalzipcode": "2333 CR",
    "entityaddresscityortown": "Leiden",
    "entityaddresscountry": "NL",
    "contactpersonnelname": "Dr. Sijmen de Vries",
    "countryregion": 31,
    "cityareacode": 71,
    "localphonenumber": "5247 400",
    "security12btitle": "American Depositary Shares, each representing ten ordinary shares, nominal value EUR 0.01 per share",
    "tradingsymbol": "PHAR",
    "securityexchangename": "NASDAQ",
    "entitycommonstocksharesoutstanding": 656348225,
    "entitywellknownseasonedissuer": "Yes",
    "entityvoluntaryfilers": "No",
    "entitycurrentreportingstatus": "Yes",
    "entityinteractivedatacurrent": "Yes",
    "entityfilercategory": "Large Accelerated Filer",
    "entityemerginggrowthcompany": "false",
    "icfrauditorattestationflag": "true",
    "documentaccountingstandard": "International Financial Reporting Standards",
    "entityshellcompany": "false",
    "entitycentralindexkey": 1828316,
    "documentfiscalyearfocus": 2022,
    "documentfiscalperiodfocus": "FY",
    "amendmentflag": "false",
    "auditorfirmid": 1243,
    "auditorname": "Deloitte Accountants B.V.",
    "auditorlocation": "Amsterdam, The Netherlands",
    "revenuefromcontractswithcustomers": 205622000,
    "costofsales": 17562000,
    "grossprofit": 188060000,
    "otherincome": 14523000,
    "researchanddevelopmentexpense": 52531000,
    "generalandadministrativeexpense": 46016000,
    "salesandmarketingexpense": 85803000,
    "operatingexpenseexcludingcostofsales": 184350000,
    "profitlossfromoperatingactivities": 18233000,
    "gainslossesonchangeinfairvalueofderivatives": -1185000,
    "otherfinanceincome": 4485000,
    "otherfinancecost": 5463000,
    "financeincomecost": -2163000,
    "shareofprofitlossofassociatesandjointventuresaccountedforusingequitymethod": -1083000,
    "profitlossbeforetax": 14987000,
    "incometaxexpensecontinuingoperations": 1313000,
    "profitloss": 13674000,
    "basicearningslosspershare": 0.021,
    "dilutedearningslosspershare": 0.019,
    "othercomprehensiveincomenetoftaxexchangedifferencesontranslation": -10349000,
    "othercomprehensiveincomenetoftaxfinancialassetsmeasuredatfairvaluethroughothercomprehensiveincome": -705000,
    "othercomprehensiveincomethatwillbereclassifiedtoprofitorlossnetoftax": -11054000,
    "othercomprehensiveincome": -11054000,
    "comprehensiveincome": 2620000,
    "intangibleassetsotherthangoodwill": 75121000,
    "propertyplantandequipment": 10392000,
    "rightofuseassets": 28753000,
    "noncurrentprepayments": 228000,
    "deferredtaxliabilityasset": -22973000,
    "investmentsinassociatesaccountedforusingequitymethod": 2501000,
    "noncurrentinvestmentsinequityinstrumentsdesignatedatfairvaluethroughothercomprehensiveincome": 403000,
    "noncurrentfinancialassetsatfairvaluethroughprofitorloss": 6827000,
    "noncurrentrestrictedcashandcashequivalents": 1099000,
    "noncurrentassets": 148297000,
    "inventories": 42326000,
    "tradeandothercurrentreceivables": 27619000,
    "currentrestrictedcashandcashequivalents": 213000,
    "cashandcashequivalents": 207342000,
    "currentassets": 277500000,
    "assets": 425797000,
    "issuedcapital": 7509000,
    "sharepremium": 462297000,
    "otherreserves": -8737000,
    "retainedearnings": -256431000,
    "equity": 204638000,
    "noncurrentportionofnoncurrentbondsissued": 131618000,
    "noncurrentleaseliabilities": 29843000,
    "noncurrentliabilities": 161461000,
    "currentbondsissuedandcurrentportionofnoncurrentbondsissued": 1768000,
    "tradeandothercurrentpayables": 54465000,
    "currentleaseliabilities": 3465000,
    "currentliabilities": 59698000,
    "equityandliabilities": 425797000,
    "increasedecreasethroughtransfertostatutoryreserve": -1083000,
    "decreaseincreasethroughtaxonsharebasedpaymenttransactions": -430000,
    "increasedecreasethroughsharebasedpaymenttransactions": 6392000,
    "increasedecreasethroughexerciseofoptions": 80000,
    "increasedecreasethroughtransactionswithowners": 80000,
    "adjustmentsfordepreciationandamortisationexpenseandimpairmentlossreversalofimpairmentlossrecognisedinprofitorloss": 13188000,
    "adjustmentsforsharebasedpayments": 6392000,
    "adjustmentsforgainlossondisposalofinvestmentsinsubsidiariesjointventuresandassociates": 12242000,
    "adjustmentsforgainslossesonchangeinfairvalueofderivatives": -1185000,
    "adjustmentsforfinanceincome": 4485000,
    "adjustmentsforfinancecosts": 5463000,
    "adjustmentsforundistributedprofitsofinvestmentsaccountedforusingequitymethod": -1083000,
    "otheradjustmentstoreconcileprofitloss": -1576000,
    "cashflowsfromusedinoperationsbeforechangesinworkingcapital": 23995000,
    "adjustmentsfordecreaseincreaseininventories": -15016000,
    "adjustmentsfordecreaseincreaseintradeandotherreceivables": 2364000,
    "adjustmentsforincreasedecreaseintradeandotherpayables": 11992000,
    "cashflowsfromusedindecreaseincreaseinrestrictedcashandcashequivalentsoperatingactivities": 273000,
    "increasedecreaseinworkingcapital": 387000,
    "interestreceivedclassifiedasoperatingactivities": 85000,
    "incometaxespaidrefundclassifiedasoperatingactivities": 1235000,
    "cashflowsfromusedinoperatingactivities": 22458000,
    "purchaseofpropertyplantandequipmentclassifiedasinvestingactivities": 1376000,
    "purchaseofintangibleassetsexcludinglicensesclassifiedasinvestingactivities": 601000,
    "proceedsfromsalesofinterestsinassociates": 7300000,
    "purchaseofinvestmentsotherthaninvestmentsaccountedforusingequitymethod": 7933000,
    "cashflowsfromusedininvestingactivities": 5323000,
    "paymentsofleaseliabilitiesclassifiedasfinancingactivities": 3311000,
    "interestpaidclassifiedasfinancingactivities": 3952000,
    "proceedsfromissuingotherequityinstruments": 2281000,
    "cashflowsfromusedinfinancingactivities": -4982000,
    "increasedecreaseincashandcashequivalentsbeforeeffectofexchangeratechanges": 22799000,
    "effectofexchangeratechangesoncashandcashequivalents": -7381000,
    "numberofmarkets": 30,
    "cashandcashequivalentsandrestrictedcashandcashequivalents": 208700000,
    "closingforeignexchangerate": 1.0667,
    "averageforeignexchangerate": 1.0543,
    "usefullifemeasuredasperiodoftimeintangibleassetsotherthangoodwill": "P6Y",
    "remainingamortisationperiodofintangibleassetsmaterialtoentity2019": "P14Y",
    "usefullifemeasuredasperiodoftimepropertyplantandequipment": "P10Y",
    "periodofservicebyemployeedefinedcontributionpension": "P6M",
    "employeeageeligiblefordefinedcontributionpension": "P18Y",
    "amountmatchedbyemployerdefinedcontributionpensionpercentage": 1,
    "employeecontributiondefinedcontributionpensionpercentage": 0.03,
    "vestingrequirementsforshareoptionsinsharebasedpaymentarrangementvestingperiod": "P5Y",
    "vestingrequirementsforsharebasedpaymentarrangementvestingperiod": "P3Y",
    "sharebasedpaymentarrangementserviceperiod": "P3Y",
    "performancerequirementsforsharebasedpaymentarrangementtotalshareholderreturnpercent": 0.4,
    "performancerequirementsforsharebasedpaymentarrangementlongtermstrategyorientedobjectivespercent": 0.6,
    "sharebasedpaymentarrangementperformanceperiod": "P3Y",
    "retentionrequirementforsharebasedpaymentarrangementretentionperiod": "P5Y",
    "gainsondisposalsofinvestments": 12200000,
    "percentageofentitysrevenue": 0.84,
    "revenuefromgovernmentgrants": 1774000,
    "otherincomeother": 507000,
    "gainrecognizedfromsaleofpreferencesharesinassociate": 7900000,
    "gainrecognizedfromsaleofordinarysharesinassociate": 4300000,
    "costofsalesexcludinginventorywritedown": 17398000,
    "inventorywritedownincludedincostofsales": 164000,
    "researchanddevelopmentdirectoperatingexpenses": 27107000,
    "researchanddevelopmentemployeecosts": 20595000,
    "researchanddevelopmentamortizationcostsifa": 55000,
    "researchanddevelopmentdepreciation": 1602000,
    "researchanddevelopmentotherindirectresearchanddevelopmentcosts": 3172000,
    "generalandadministrativeemployeecosts": 14868000,
    "generalandadministrativeamortisationcostsifa": 492000,
    "generalandadministrativedepreciationppe": 2525000,
    "generalandadministrativeimpairmentlossesofpropertyplantandequipment": 4376000,
    "generalandadministrativedirectoperatingexpenses": 9038000,
    "generalandadministrativeotherindirectgeneralandadministrativeexpense": 14717000,
    "marketingandsalesemployeecosts": 32858000,
    "marketingandsalesamortisationcostsifa": 3765000,
    "marketingandsalesdepreciation": 372000,
    "marketingandsalesdirectoperatingexpenses": 42398000,
    "marketingandsalesotherindirectmarketingandsalescosts": 6410000,
    "wagesandsalaries": 53328000,
    "socialsecuritycontributions": 6317000,
    "postemploymentbenefitexpensedefinedbenefitplans": 2284000,
    "expensefromsharebasedpaymenttransactionswithemployees": 6392000,
    "employeebenefitsexpense": 68321000,
    "depreciationandamortisationexpense": 1993000,
    "investmentincome": 85000,
    "foreignexchangegain": 4400000,
    "interestexpenseonborrowings": 4736000,
    "interestexpenseonleaseliabilities": 622000,
    "financecosts": 105000,
    "otherfinanceincomecost": -978000,
    "currenttaxexpenseincome": 3761000,
    "adjustmentsforcurrenttaxofpriorperiod": 9000,
    "currenttaxexpenseincomeandadjustmentsforcurrenttaxofpriorperiods": 3770000,
    "deferredtaxexpenseincomebeforeadjustments": -2581000,
    "adjustmentsfordeferredtaxofpriorperiods": 124000,
    "deferredtaxexpenseincometotal": -2457000,
    "accountingprofit": 14987000,
    "taxexpenseincomeatapplicabletaxrate": 3866000,
    "taxeffectofforeigntaxrates": -554000,
    "taxeffectofincomeexpensefromtaxation": 2142000,
    "taxeffectadjustmentsofpriorperiod": 15000,
    "taxeffectfromchangeintaxrate": 1000,
    "othertaxeffectsforreconciliationbetweenaccountingprofitandtaxexpenseincome": 157000,
    "deferredtaxassets": 29211000,
    "deferredtaxliabilities": 6238000,
    "deferredtaxexpenseincomerecognisedinprofitorloss": -3431000,
    "increasedecreasethroughotherchangesdeferredtaxliabilityasset": -28000,
    "deferredtaxrelatingtoitemschargedorcrediteddirectlytoequity": 337000,
    "deferredtaxassetrelatingtocurrencytranslation": -617000,
    "netdeferredtaxassetscurrent": 5400000,
    "deferredtaxliabilityrelatingtocurrencytranslation": -185000,
    "amortisationintangibleassetsotherthangoodwill": 3597000,
    "acquisitionsthroughbusinesscombinationsintangibleassetsotherthangoodwill": 601000,
    "disposalsintangibleassetsotherthangoodwill": 6431000,
    "increasedecreasethroughnetexchangedifferencesintangibleassetsotherthangoodwill": -35000,
    "changesinintangibleassetsotherthangoodwill": -16000,
    "additionsotherthanthroughbusinesscombinationspropertyplantandequipment": 54000,
    "increasedecreasethroughtransferspropertyplantandequipment": 42000,
    "disposalspropertyplantandequipment": 29000,
    "impairmentlossrecognisedinprofitorlosspropertyplantandequipment": 72000,
    "depreciationpropertyplantandequipment": 403000,
    "depreciationpropertyplantandequipmentdisposals": 214000,
    "increasedecreasethroughnetexchangedifferencespropertyplantandequipment": -2000,
    "changesinpropertyplantandequipment": -31000,
    "depreciationexpense": 1600000,
    "additionstorightofuseassets": 15066000,
    "disposalsofrightofuseassets": 292000,
    "depreciationrightofuseassets": 2223000,
    "depreciationrightofuseassetsdisposals": 78000,
    "rightofuseassetsimpairment": 3860000,
    "depreciationrightofuseassetsimpairment": 59000,
    "increasedecreasethroughnetexchangedifferencesrightofuseassets": -1029000,
    "increasedecreaseinrightofuseassets": 7996000,
    "significantunobservableinputassets": 0.05,
    "rentalexpense": 3642000,
    "leasesremainingleaseterm": "P1Y",
    "proportionofownershipinterestinassociate": 0.2298,
    "shareofprofitlossofassociatesaccountedforusingequitymethod": -1083000,
    "investmentsaccountedforusingequitymethodfinancialguaranteeamortization": 153000,
    "investmentsaccountedforusingequitymethoddilutionofequitystake": 2991000,
    "investmentsaccountedforusingequitymethodcurrencytranslation": -473000,
    "gainslossesonfinancialassetsatfairvaluethroughprofitorloss": -1185000,
    "noncurrentinvestmentsinequityinstrumentsdesignatedatfairvaluethroughprofitorlosscurrencytranslation": 79000,
    "percentageofordinarysharestradedatstockexchange": 0.99,
    "gainslossesonfinancialassetsmeasuredatfairvaluethroughothercomprehensiveincomenetoftax": -950000,
    "noncurrentinvestmentsinequityinstrumentsdesignatedatfairvaluethroughothercomprehensiveincomecurrencytranslation": -96000,
    "restrictedcashandcashequivalents": 1300000,
    "finishedgoods": 12460000,
    "workinprogress": 29553000,
    "rawmaterials": 313000,
    "inventorywritedown2011": 164000,
    "reversalofinventorywritedown": 312000,
    "inventoryusageofwritedownprovision": 195000,
    "inventorycurrencytranslation": 134000,
    "currenttradereceivables": 20964000,
    "currentprepayments": 2288000,
    "currentvalueaddedtaxreceivables": 1453000,
    "othercurrentreceivables": 1117000,
    "currentreceivablesfromtaxesandsocialsecurities": 1797000,
    "borrowings": 133386000,
    "borrowingcostsrecognisedasexpense": 784000,
    "interestexpenseonborrowingsnotyetpaid": 3952000,
    "convertiblebondscurrencytranslation": -8284000,
    "currentborrowingsandcurrentportionofnoncurrentborrowings": 1768000,
    "longtermborrowings": 131618000,
    "borrowingsinterestrate": 0.03,
    "leaseliabilities": 33308000,
    "increasethroughnewleasesliabilitiesarisingfromfinancingactivities": 16248000,
    "increasedecreasethroughinterestexpenseliabilitiesarisingfromfinancingactivities": 718000,
    "increasedecreasethroughfinancingcashflowsliabilitiesarisingfromfinancingactivities": -3311000,
    "leaseliabilitiesothermovements": -348000,
    "leaseliabilitiescurrencytranslation": -874000,
    "grossleaseliabilities": 4644000,
    "tradeandothercurrentpayablestotradesuppliers": 8753000,
    "currentpayablesonsocialsecurityandtaxesotherthanincometax": 2099000,
    "accrualsrebatesanddiscountscurrent": 12139000,
    "accrualsproductioncostscurrent": 10490000,
    "accrualsothercurrent": 8175000,
    "othercurrentpayables": 12809000,
    "sharebasedpaymentshareauthorizationperiodforissuance": "P18M",
    "expensefromsharebasedpaymenttransactionsinwhichgoodsorservicesreceiveddidnotqualifyforrecognitionasassets": 6400000,
    "sharebasedpaymentarrangementnumberofvestingtranches": 4,
    "numberofelementsusedinoptionpricingmodel": 6,
    "numberofminimumyearsoptionlife": "P3Y",
    "maximumgrantedoptionspercentageoverissuedandoutstandingshares": 0.1,
    "vestingrequirementsforsharebasedpaymentarrangementoptionsmaximumvestingperiod": "P5Y",
    "sharebasedpaymentarrangementoptionsminimumperiodtobedeemedlapsed": "P5Y",
    "descriptionofoptionlifeshareoptionsgranted": 1,
    "descriptionofexpectedvolatilityshareoptionsgranted": 0.36,
    "descriptionofriskfreeinterestrateshareoptionsgranted": -0.0048,
    "sharebasedpaymentarrangementoptionsterminationofemploymentminimumperiodtobedeemedlapsed": "P1Y",
    "expectedvolatilityhistoricalendofmonthclosingsharepricesduration": "P3Y",
    "expectedcorrelationshistoricalcorrelationsbasedonendofmonthclosingquotesperiod": "P3Y",
    "sharebasedpaymentontargetvalueofsharestobeawardedpercentageofgrossannualsalary": 3,
    "sharebasedpaymentontargetvalueofsharestobeawardedpercentagebelowthelowestquartileofusbenchmarkgroup": 0.5,
    "sharebasedpaymentmaximumvalueofsharesthatcanvestunderprogrampercentageofgrossannualsalary": 4.5,
    "sharebasedpaymentexecutivedirectorsminimumretentionperiodofsharesawardedunderprogram": "P5Y",
    "sharebasedpaymentexecutivedirectorsvestingperiodaftergrantdate": "P3Y",
    "sharebasedpaymentexecutivedirectorsperformanceperiod": "P3Y",
    "sharebasedpaymentexecutivedirectorsminimumretentionperiodofsharesawardedunderprogramperiodaftervestingdate": "P2Y",
    "sharebasedpaymentexecutivedirectorsperformanceindicatortotalshareholderreturnpercentage": 0.4,
    "sharebasedpaymentexecutivedirectorsperformanceindicatorlongtermstrategyorientedobjectivespercentage": 0.6,
    "sharebasedpaymentexecutivedirectorsindexweightpayoutpercentage": 0.5,
    "sharebasedpaymentexecutivedirectorstotalshareholderreturnoverindexpercentage": 0.1,
    "sharebasedpaymentexecutivedirectorspayoutpercentage": 0.8,
    "sharebasedpaymentarrangementotherequityinstrumentsexpectedvolatility": 0.46,
    "sharebasedpaymentarrangementotherequityinstrumentsriskfreeinterestrate": 0.0061,
    "numberofshareoptionsvestedinsharebasedpaymentarrangement": 8687584,
    "numberofoutstandingshareoptions": 47596801,
    "numberofshareoptionsforfeitedinsharebasedpaymentarrangement": 3660928,
    "numberofshareoptionsgrantedinsharebasedpaymentarrangement": 4801938,
    "numberofshareoptionsexercisedinsharebasedpaymentarrangement": 6333687,
    "numberofshareoptionsunvestedinsharebasedpaymentarrangement": 38909217,
    "weightedaverageexercisepriceofshareoptionsoutstandinginsharebasedpaymentarrangement2019": 0.897,
    "weightedaverageexercisepriceofshareoptionsforfeitedinsharebasedpaymentarrangement2019": 0.847,
    "weightedaverageexercisepriceofshareoptionsgrantedinsharebasedpaymentarrangement2019": 0.902,
    "weightedaverageexercisepriceofshareoptionsexercisedinsharebasedpaymentarrangement2019": 0.599,
    "weightedaverageexercisepriceofshareoptionsvestedinsharebasedpaymentarrangement": 0.844,
    "weightedaverageexercisepriceofshareoptionsunvestedinsharebasedpaymentarrangement": 0.91,
    "exercisepriceofoutstandingshareoptions2019": 0.071,
    "exercisevalueofshareoptionsoutstandinginsharebasedpaymentarrangement": 21847000,
    "exercisepriceshareoptionsgranted2019": 0.092,
    "numberofinstrumentsotherequityinstrumentsgranted": 205000,
    "weightedaverageexercisepriceofotherequityinstrumentsgrantedinsharebasedpaymentarrangement2019": 0.517,
    "numberofotherequityinstrumentsforfeitedinsharebasedpaymentarrangement": 18000,
    "numberofotherequityinstrumentsnotvestedinsharebasedpaymentarrangement": 187000,
    "numberofotherequityinstrumentsreservedinsharebasedpaymentarrangement": 3701343,
    "sharebasedpaymentexecutivedirectorsachievementlevelpercentage": 1.15,
    "sharebasedpaymentexecutivedirectorsweightinglevelpercentage": 0.4,
    "sharebasedpaymentexecutivedirectorsvestinglevelpercentage": 0.46,
    "keymanagementpersonnelcompensationadditionalcompensationamountperday": 1000,
    "keymanagementpersonnelcompensationbasesalary": 65000,
    "keymanagementpersonnelcompensationsharebasedpayment": 40000,
    "sharebasedpaymentsharevaluationvolumeweightedaveragepriceduration": "P20D",
    "directorsremunerationexpensebasesalary": 72000,
    "directorsremunerationexpensesharebasedpayment": 42000,
    "directorsremunerationexpense": 114000,
    "numberofsharesinentityheldbyrelatedparties": 486037,
    "keymanagementpersonnelcompensationshorttermemployeebenefits": 394000,
    "keymanagementpersonnelcompensationpostemploymentbenefits": 112000,
    "keymanagementpersonnelcompensationother": 34000,
    "keymanagementpersonnelcompensation": 2396000,
    "sharesreservedforissueunderoptionsandcontractsforsaleofshares": 2363455,
    "purchasesofgoodsrelatedpartytransactions": 3000000,
    "servicefeesreceivablerelatedpartytransactions": 500000,
    "contractualcapitalcommitments": 73800000,
    "royaltyfeesovernetsalespercentage": 0.18,
    "royaltyfeesamountofnetsalestobeexceeded": 300000000,
    "royaltyfeespaymentterm": "P10Y",
    "royaltyfeesminimumroyaltyliabilitypercentage": 0.12,
    "royaltyfeesminimumroyaltyliabilityapplicablesaleslimit": 150000000,
    "contractualagreementrighttopurchasevoucherterm": "P3Y",
    "cash": 150300000,
    "cashandcashequivalentsrestrictedcashaccountsreceivableandinventories": 82100000,
    "balancesdenominatedinothercurrency": 58300000,
    "sensitivityanalysisimpactoftenpercentstrengtheningofothercurrencyagainsttheusdollar": 5800000,
    "sensitivityanalysisimpactoftenpercentweakeningofothercurrencyagainsttheusdollar": -5800000,
    "financialassets": 208654000,
    "tradeandotherpayablesundiscountedcashflows": 54465000,
    "bondsissuedundiscountedcashflows": 4000000,
    "derivativeandnonderivativefinancialliabilitiesundiscountedcashflows": 63109000,
    "financialassetsatfairvalue": 208654000,
    "financialliabilities": 133386000,
    "financialliabilitiesatfairvalue": 133386000,
    "bankborrowingsundiscountedcashflows": 1768000,
    "undiscountedcontractualamountsdueincludingnominalinterest": 75268000,
    "liabilitiesarisingfromfinancingactivities": 133386000,
    "increasedecreasethroughobtainingorlosingcontrolofsubsidiariesorotherbusinessesliabilitiesarisingfromfinancingactivities": -165000,
    "increasedecreasethroughamortizedcostsliabilitiesarisingfromfinancingactivities": 784000,
    "increasedecreasethroughotherchangesliabilitiesarisingfromfinancingactivities": -8284000,
    "weightedaverageshares": 648676119,
    "adjustedweightedaverageshares": 707141263,
    "numberofconvertiblebondsoutstanding": 62412622,
    "numberofsharesoutstandingdiluted": 656348225,
    "numberofrestrictedstockunitsoutstanding": 4931000,
    "numberofotherequityinstrumentsoutstandinginsharebasedpaymentarrangement": 15304821,
    "numberofsharesandotherinstrumentsoutstanding": 786593469,
    "numberofsharesauthorised": 880000000,
    "authorisedsharecapital": 9400000,
    "parvaluepershare": 0.01,
    "numberofsharesoutstanding": 656348225,
    "increasedecreasethroughtransfertootherreserveequity": -10349000
  },
  {
    "date": "2021-12-31",
    "symbol": "PHAR",
    "period": "FY",
    "documenttype": "20-F",
    "documentregistrationstatement": "false",
    "documentannualreport": "true",
    "documentperiodenddate": "2021-12-31",
    "currentfiscalyearenddate": "--12-31",
    "documenttransitionreport": "false",
    "documentshellcompanyreport": "false",
    "entityfilenumber": "001-39822",
    "entityregistrantname": "Pharming Group N.V.",
    "entityincorporationstatecountrycode": "P7",
    "entityaddressaddressline1": "Darwinweg 24",
    "entityaddressaddressline2": "Suite 401",
    "entityaddresspostalzipcode": "2333 CR",
    "entityaddresscityortown": "Leiden",
    "entityaddresscountry": "NL",
    "contactpersonnelname": "Pharming Healthcare Inc.",
    "entityaddressstateorprovince": "NJ",
    "cityareacode": 908,
    "localphonenumber": "524 0888",
    "security12btitle": "American Depositary Shares, each representing ten ordinary shares, nominal value EUR 0.01 per share",
    "tradingsymbol": "PHAR",
    "securityexchangename": "NASDAQ",
    "entitycommonstocksharesoutstanding": 648749000,
    "entitywellknownseasonedissuer": "No",
    "entityvoluntaryfilers": "No",
    "entitycurrentreportingstatus": "Yes",
    "entityinteractivedatacurrent": "Yes",
    "entityfilercategory": "Non-accelerated Filer",
    "entityemerginggrowthcompany": "false",
    "documentaccountingstandard": "International Financial Reporting Standards",
    "entityshellcompany": "false",
    "entitycentralindexkey": 1828316,
    "documentfiscalyearfocus": 2021,
    "documentfiscalperiodfocus": "FY",
    "amendmentflag": "false",
    "auditorfirmid": 1243,
    "auditorname": "Deloitte Accountants B.V.",
    "auditorlocation": "Amsterdam, The Netherlands",
    "revenuefromcontractswithcustomers": 198871000,
    "costofsales": 21142000,
    "grossprofit": 177729000,
    "revenuefromgovernmentgrants": 2620000,
    "researchanddevelopmentexpense": 70369000,
    "generalandadministrativeexpense": 36974000,
    "salesandmarketingexpense": 59445000,
    "operatingexpenseexcludingcostofsales": 166788000,
    "profitlossfromoperatingactivities": 13561000,
    "gainslossesonchangeinfairvalueofderivatives": 114000,
    "otherfinanceincome": 14894000,
    "otherfinancecost": 6185000,
    "financeincomecost": 8823000,
    "shareofprofitlossofassociatesandjointventuresaccountedforusingequitymethod": 694000,
    "profitlossbeforetax": 23078000,
    "incometaxexpensecontinuingoperations": 7082000,
    "profitloss": 15996000,
    "basicearningslosspershare": 0.025,
    "dilutedearningslosspershare": 0.023,
    "othercomprehensiveincomenetoftaxexchangedifferencesontranslation": -14802000,
    "othercomprehensiveincomenetoftaxfinancialassetsmeasuredatfairvaluethroughothercomprehensiveincome": -2283000,
    "othercomprehensiveincomethatwillbereclassifiedtoprofitorlossnetoftax": -17085000,
    "othercomprehensiveincome": -17085000,
    "comprehensiveincome": -1089000,
    "intangibleassetsotherthangoodwill": 83834000,
    "propertyplantandequipment": 13222000,
    "rightofuseassets": 19943000,
    "noncurrentprepayments": 194000,
    "deferredtaxliabilityasset": -21216000,
    "investmentsinassociatesaccountedforusingequitymethod": 7201000,
    "noncurrentinvestmentsinequityinstrumentsdesignatedatfairvaluethroughothercomprehensiveincome": 1449000,
    "noncurrentrestrictedcashandcashequivalents": 812000,
    "noncurrentassets": 147871000,
    "inventories": 27310000,
    "tradeandothercurrentreceivables": 29983000,
    "currentrestrictedcashandcashequivalents": 227000,
    "cashandcashequivalents": 191924000,
    "currentassets": 249444000,
    "assets": 397315000,
    "issuedcapital": 7429000,
    "sharepremium": 455254000,
    "statutoryreserve": 3400000,
    "retainedearnings": -273167000,
    "equity": 192916000,
    "noncurrentportionofnoncurrentbondsissued": 139007000,
    "noncurrentleaseliabilities": 18456000,
    "othernoncurrentfinancialliabilities": 165000,
    "noncurrentliabilities": 157628000,
    "currentbondsissuedandcurrentportionofnoncurrentbondsissued": 1879000,
    "tradeandothercurrentpayables": 42473000,
    "currentleaseliabilities": 2419000,
    "currentliabilities": 46771000,
    "equityandliabilities": 397315000,
    "numberofsharesoutstanding": 648749000,
    "increasedecreasethroughtransfertostatutoryreserve": 694000,
    "decreaseincreasethroughtaxonsharebasedpaymenttransactions": 1853000,
    "increasedecreasethroughsharebasedpaymenttransactions": 9056000,
    "numberofwarrantsexercisedduringtheperiod": 61000,
    "increasedecreasethroughexerciseofwarrantsequity": 1000,
    "numberofshareoptionsexercisedinsharebasedpaymentarrangement": 9867000,
    "increasedecreasethroughexerciseofoptions": 116000,
    "transactionswithownersequitynumberofshares": 9928000,
    "increasedecreasethroughtransactionswithowners": 117000,
    "adjustmentsfordepreciationandamortisationexpenseandimpairmentlossreversalofimpairmentlossrecognisedinprofitorloss": 19610000,
    "adjustmentsforsharebasedpayments": 9056000,
    "adjustmentsforgainslossesonchangeinfairvalueofderivatives": 114000,
    "adjustmentsforfinanceincome": 14906000,
    "adjustmentsforfinancecosts": 6196000,
    "adjustmentsforundistributedprofitsofinvestmentsaccountedforusingequitymethod": 694000,
    "otheradjustmentstoreconcileprofitloss": 524000,
    "cashflowsfromusedinoperationsbeforechangesinworkingcapital": 42750000,
    "adjustmentsfordecreaseincreaseininventories": -6153000,
    "adjustmentsfordecreaseincreaseintradeandotherreceivables": 5918000,
    "adjustmentsforincreasedecreaseintradeandotherpayables": -5193000,
    "cashflowsfromusedindecreaseincreaseinrestrictedcashandcashequivalentsoperatingactivities": 467000,
    "increasedecreaseinworkingcapital": 4961000,
    "interestreceivedclassifiedasoperatingactivities": 53000,
    "cashflowsfromusedinoperatingactivities": 37842000,
    "purchaseofpropertyplantandequipmentclassifiedasinvestingactivities": 10739000,
    "purchaseofintangibleassetsexcludinglicensesclassifiedasinvestingactivities": 3447000,
    "purchaseofinvestmentsotherthaninvestmentsaccountedforusingequitymethod": 4589000,
    "purchaseofintangibleassetslicensesclassifiedasinvestingactivities": 2530000,
    "cashflowsfromusedininvestingactivities": -21305000,
    "paymentsofcontingentconsiderationsclassifiedasfinancingactivities": 25000000,
    "paymentsofleaseliabilitiesclassifiedasfinancingactivities": 3217000,
    "interestpaidclassifiedasfinancingactivities": 4448000,
    "proceedsfromissuingotherequityinstruments": 4718000,
    "cashflowsfromusedinfinancingactivities": -27947000,
    "increasedecreaseincashandcashequivalentsbeforeeffectofexchangeratechanges": -11410000,
    "effectofexchangeratechangesoncashandcashequivalents": -1825000,
    "cashandcashequivalentsandrestrictedcashandcashequivalents": 193000000,
    "closingforeignexchangerate": 1.1334,
    "averageforeignexchangerate": 1.186,
    "usefullifemeasuredasperiodoftimeintangibleassetsotherthangoodwill": "P6Y",
    "remainingamortisationperiodofintangibleassetsmaterialtoentity2019": "P15Y",
    "usefullifemeasuredasperiodoftimepropertyplantandequipment": "P20Y",
    "periodofservicebyemployeedefinedcontributionpension": "P6M",
    "employeeageeligiblefordefinedcontributionpension": "P18Y",
    "amountmatchedbyemployerdefinedcontributionpensionpercentage": 1,
    "employeecontributiondefinedcontributionpensionpercentage": 0.03,
    "vestingrequirementsforshareoptionsinsharebasedpaymentarrangementvestingperiod": "P5Y",
    "vestingrequirementsforsharebasedpaymentarrangementvestingperiod": "P3Y",
    "sharebasedpaymentarrangementserviceperiod": "P3Y",
    "performancerequirementsforsharebasedpaymentarrangementtotalshareholderreturnpercent": 0.4,
    "performancerequirementsforsharebasedpaymentarrangementlongtermstrategyorientedobjectivespercent": 0.6,
    "retentionrequirementforsharebasedpaymentarrangementretentionperiod": "P5Y",
    "leaseliabilities": 20875000,
    "percentageofentitysrevenue": 0.79,
    "costofsalesexcludinginventorywritedown": 19107000,
    "inventorywritedownincludedincostofsales": 2035000,
    "researchanddevelopmentdirectoperatingexpenses": 33190000,
    "researchanddevelopmentimpairmentlossesifa": 4992000,
    "researchanddevelopmentemployeecosts": 24451000,
    "researchanddevelopmentamortizationcostsifa": 132000,
    "researchanddevelopmentdepreciation": 3152000,
    "researchanddevelopmentotherindirectresearchanddevelopmentcosts": 4452000,
    "generalandadministrativeemployeecosts": 12178000,
    "generalandadministrativedepreciationppe": 857000,
    "generalandadministrativeimpairmentlossesofpropertyplantandequipment": 5447000,
    "generalandadministrativedirectoperatingexpenses": 8419000,
    "generalandadministrativeotherindirectgeneralandadministrativeexpense": 10073000,
    "marketingandsalesemployeecosts": 24125000,
    "marketingandsalesamortisationcostsifa": 4098000,
    "marketingandsalesdepreciation": 930000,
    "marketingandsalesdirectoperatingexpenses": 28543000,
    "marketingandsalesotherindirectmarketingandsalescosts": 1749000,
    "wagesandsalaries": 44202000,
    "socialsecuritycontributions": 5318000,
    "postemploymentbenefitexpensedefinedbenefitplans": 2179000,
    "expensefromsharebasedpaymenttransactionswithemployees": 9055000,
    "employeebenefitsexpense": 60754000,
    "depreciationandamortisationexpense": 2158000,
    "depreciationrightofuseassets": 2781000,
    "currenttaxexpenseincome": 97000,
    "adjustmentsforcurrenttaxofpriorperiod": -96000,
    "currenttaxexpenseincomeandadjustmentsforcurrenttaxofpriorperiods": 1000,
    "deferredtaxexpenseincomebeforeadjustments": 8196000,
    "adjustmentsfordeferredtaxofpriorperiods": -1115000,
    "deferredtaxexpenseincometotal": 7081000,
    "accountingprofit": 23078000,
    "taxexpenseincomeatapplicabletaxrate": 5770000,
    "taxeffectofforeigntaxrates": -307000,
    "taxeffectofrevenuesexemptfromtaxation2011": -2853000,
    "taxeffectadjustmentsofpriorperiod": 655000,
    "taxeffectfromchangeintaxrate": -555000,
    "othertaxeffectsforreconciliationbetweenaccountingprofitandtaxexpenseincome": -24000,
    "deferredtaxassets": 27025000,
    "deferredtaxliabilities": 5809000,
    "deferredtaxexpenseincomerecognisedinprofitorloss": 6121000,
    "increasedecreasethroughotherchangesdeferredtaxliabilityasset": -598000,
    "deferredtaxrelatingtoitemschargedorcrediteddirectlytoequity": -1366000,
    "deferredtaxassetrelatingtocurrencytranslation": -1091000,
    "netdeferredtaxassetscurrent": 2400000,
    "deferredtaxliabilityrelatingtocurrencytranslation": -209000,
    "amortisationintangibleassetsotherthangoodwill": 4054000,
    "impairmentlossrecognisedinprofitorlossintangibleassetsotherthangoodwill": -4991000,
    "acquisitionsthroughbusinesscombinationsintangibleassetsotherthangoodwill": 2530000,
    "increasedecreasethroughtransfersintangibleassetsotherthangoodwill": 175000,
    "disposalsintangibleassetsotherthangoodwill": 3145000,
    "increasedecreasethroughnetexchangedifferencesintangibleassetsotherthangoodwill": -111000,
    "changesinintangibleassetsotherthangoodwill": -5189000,
    "purchaseofintangibleassetsclassifiedasinvestingactivities": 2500000,
    "additionsotherthanthroughbusinesscombinationspropertyplantandequipment": 27000,
    "increasedecreasethroughtransferspropertyplantandequipment": -544000,
    "increasedecreasethroughotherchangespropertyplantandequipment": -175000,
    "disposalspropertyplantandequipment": 2000,
    "depreciationpropertyplantandequipment": 455000,
    "depreciationpropertyplantandequipmentdisposals": 2000,
    "increasedecreasethroughnetexchangedifferencespropertyplantandequipment": -2000,
    "changesinpropertyplantandequipment": -2000,
    "impairmentlossrecognisedinprofitorlosspropertyplantandequipment": 5400000,
    "depreciationexpense": 2100000,
    "additionstorightofuseassets": 13802000,
    "disposalsofrightofuseassets": 51000,
    "depreciationrightofuseassetsdisposals": 30000,
    "othermovementofrightofuseassets": -478000,
    "increasedecreasethroughnetexchangedifferencesrightofuseassets": -1148000,
    "increasedecreaseinrightofuseassets": 10932000,
    "interestexpenseonleaseliabilities": 795000,
    "rentalexpense": 3576000,
    "leasesremainingleaseterm": "P1Y",
    "proportionofownershipinterestinassociate": 0.4385,
    "shareofprofitlossofassociatesaccountedforusingequitymethod": 694000,
    "investmentsaccountedforusingequitymethodfinancialguaranteeamortization": -33000,
    "investmentsaccountedforusingequitymethodcurrencytranslation": -578000,
    "percentageofordinarysharestradedatstockexchange": 0.99,
    "gainslossesonfinancialassetsmeasuredatfairvaluethroughothercomprehensiveincomenetoftax": -3077000,
    "noncurrentinvestmentsinequityinstrumentsdesignatedatfairvaluethroughothercomprehensiveincomecurrencytranslation": -63000,
    "restrictedcashandcashequivalents": 1000000,
    "finishedgoods": 13560000,
    "workinprogress": 9606000,
    "rawmaterials": 4144000,
    "inventorywritedown2011": 2342000,
    "reversalofinventorywritedown": 20000,
    "inventoryusageofwritedownprovision": 407000,
    "inventorycurrencytranslation": 113000,
    "currenttradereceivables": 18076000,
    "currentprepayments": 2392000,
    "currentvalueaddedtaxreceivables": 2486000,
    "othercurrentreceivables": 2363000,
    "currentreceivablesfromtaxesandsocialsecurities": 4666000,
    "borrowings": 140886000,
    "borrowingcostsrecognisedasexpense": 849000,
    "interestexpenseonborrowingsnotyetpaid": 4447000,
    "convertiblebondscurrencytranslation": -11729000,
    "currentborrowingsandcurrentportionofnoncurrentborrowings": 1879000,
    "longtermborrowings": 139007000,
    "borrowingsinterestrate": 0.03,
    "increasethroughnewleasesliabilitiesarisingfromfinancingactivities": 14118000,
    "increasedecreasethroughinterestexpenseliabilitiesarisingfromfinancingactivities": 680000,
    "increasedecreasethroughfinancingcashflowsliabilitiesarisingfromfinancingactivities": -3217000,
    "leaseliabilitiesothermovements": 94000,
    "leaseliabilitiescurrencytranslation": -992000,
    "grossleaseliabilities": 3118000,
    "tradeandothercurrentpayablestotradesuppliers": 7599000,
    "currentpayablesonsocialsecurityandtaxesotherthanincometax": 1505000,
    "shorttermemployeebenefitsaccruals": 34000,
    "accrualsrebatesanddiscountscurrent": 8850000,
    "accrualsproductioncostscurrent": 11111000,
    "accrualsothercurrent": 5760000,
    "othercurrentpayables": 7614000,
    "expensefromsharebasedpaymenttransactionsinwhichgoodsorservicesreceiveddidnotqualifyforrecognitionasassets": 9100000,
    "numberofelementsusedinoptionpricingmodel": 6,
    "numberofminimumyearsoptionlife": "P3Y",
    "maximumgrantedoptionspercentageoverissuedandoutstandingshares": 0.1,
    "vestingrequirementsforsharebasedpaymentarrangementoptionsmaximumvestingperiod": "P5Y",
    "sharebasedpaymentarrangementoptionsminimumperiodtobedeemedlapsed": "P5Y",
    "expectedvolatilityhistoricalendofmonthclosingsharepricesduration": "P3Y",
    "expectedcorrelationshistoricalcorrelationsbasedonendofmonthclosingquotesperiod": "P3Y",
    "descriptionofoptionlifeshareoptionsgranted": 1,
    "descriptionofexpectedvolatilityshareoptionsgranted": 0.47,
    "descriptionofriskfreeinterestrateshareoptionsgranted": -0.0052,
    "numberofpeereuropeanbiotechcompanies": 22,
    "sharebasedpaymentarrangementachievementlevelpercentage": 0.05,
    "sharebasedpaymentarrangementgrantattainedpercentage": 1,
    "sharebasedpaymentontargetvalueofsharestobeawardedpercentageofgrossannualsalary": 3,
    "sharebasedpaymentontargetvalueofsharestobeawardedpercentagebelowthelowestquartileofusbenchmarkgroup": 0.5,
    "sharebasedpaymentmaximumvalueofsharesthatcanvestunderprogrampercentageofgrossannualsalary": 4.5,
    "sharebasedpaymentexecutivedirectorsminimumretentionperiodofsharesawardedunderprogram": "P5Y",
    "sharebasedpaymentexecutivedirectorsvestingperiodaftergrantdate": "P3Y",
    "sharebasedpaymentexecutivedirectorsperformanceperiod": "P3Y",
    "sharebasedpaymentexecutivedirectorsminimumretentionperiodofsharesawardedunderprogramperiodaftervestingdate": "P2Y",
    "sharebasedpaymentexecutivedirectorsperformanceindicatortotalshareholderreturnpercentage": 0.4,
    "sharebasedpaymentexecutivedirectorsperformanceindicatorlongtermstrategyorientedobjectivespercentage": 0.6,
    "sharebasedpaymentexecutivedirectorsindexweightpayoutpercentage": 0.5,
    "sharebasedpaymentexecutivedirectorstotalshareholderreturnoverindexpercentage": 0.1,
    "sharebasedpaymentexecutivedirectorspayoutpercentage": 0.8,
    "numberofshareoptionsvestedinsharebasedpaymentarrangement": 21388237,
    "numberofoutstandingshareoptions": 52789478,
    "numberofshareoptionsforfeitedinsharebasedpaymentarrangement": 946738,
    "numberofshareoptionsgrantedinsharebasedpaymentarrangement": 12081000,
    "numberofshareoptionsunvestedinsharebasedpaymentarrangement": 31401241,
    "weightedaverageexercisepriceofshareoptionsoutstandinginsharebasedpaymentarrangement2019": 0.911,
    "weightedaverageexercisepriceofshareoptionsforfeitedinsharebasedpaymentarrangement2019": 1.046,
    "weightedaverageexercisepriceofshareoptionsgrantedinsharebasedpaymentarrangement2019": 0.931,
    "weightedaverageexercisepriceofshareoptionsexercisedinsharebasedpaymentarrangement2019": 0.52,
    "weightedaverageexercisepriceofshareoptionsvestedinsharebasedpaymentarrangement": 0.833,
    "weightedaverageexercisepriceofshareoptionsunvestedinsharebasedpaymentarrangement": 0.966,
    "sharebasedpaymentarrangementoptionsterminationofemploymentminimumperiodtobedeemedlapsed": "P1Y",
    "numberofinstrumentsotherequityinstrumentsgranted": 205000,
    "exercisepriceofoutstandingshareoptions2019": 0.071,
    "exercisevalueofshareoptionsoutstandinginsharebasedpaymentarrangement": 1322000000,
    "exercisepriceshareoptionsgranted2019": 0.891,
    "weightedaverageexercisepriceofotherequityinstrumentsgrantedinsharebasedpaymentarrangement2019": 0.887,
    "numberofotherequityinstrumentsforfeitedinsharebasedpaymentarrangement": 115000,
    "numberofotherequityinstrumentsnotvestedinsharebasedpaymentarrangement": 72000,
    "numberofotherequityinstrumentsreservedinsharebasedpaymentarrangement": 18000,
    "sharebasedpaymentexecutivedirectorsachievementlevelpercentage": 0.75,
    "sharebasedpaymentexecutivedirectorsweightinglevelpercentage": 0.4,
    "sharebasedpaymentexecutivedirectorsvestinglevelpercentage": 0.45,
    "numberoftiersboardofmanagementpriortolisting": 2,
    "numberoftiersboardofmanagement": 1,
    "keymanagementpersonnelcompensationadditionalcompensationamountperday": 1000,
    "keymanagementpersonnelcompensationbasesalary": 65000,
    "keymanagementpersonnelcompensationsharebasedpayment": 40000,
    "sharebasedpaymentsharevaluationvolumeweightedaveragepriceduration": "P20D",
    "directorsremunerationexpensebasesalary": 77000,
    "directorsremunerationexpensesharebasedpayment": 55000,
    "directorsremunerationexpense": 132000,
    "sharesreservedforissueunderoptionsandcontractsforsaleofshares": 1337888,
    "numberofsharesinentityheldbyrelatedparties": 423985,
    "keymanagementpersonnelcompensationshorttermemployeebenefits": 357000,
    "keymanagementpersonnelcompensationpostemploymentbenefits": 120000,
    "keymanagementpersonnelcompensationother": 38000,
    "keymanagementpersonnelcompensation": 2460000,
    "amountspayablerelatedpartytransactions": 100000,
    "purchasesofgoodsrelatedpartytransactions": 3500000,
    "otherfinancialliabilities": 165000,
    "contractualcapitalcommitments": 97300000,
    "leaseagreementofficebuildingterm": "P15Y",
    "maximumcommitmentliability": 200000000,
    "royaltyfeesovernetsalespercentage": 0.18,
    "royaltyfeesamountofnetsalestobeexceeded": 300000000,
    "royaltyfeespaymentterm": "P10Y",
    "financialassets": 192963000,
    "cash": 130700000,
    "cashandcashequivalentsrestrictedcashaccountsreceivableandinventories": 87300000,
    "balancesdenominatedinothercurrency": 67100000,
    "sensitivityanalysisimpactoftenpercentstrengtheningofothercurrencyagainsttheusdollar": 6700000,
    "sensitivityanalysisimpactoftenpercentweakeningofothercurrencyagainsttheusdollar": -6700000,
    "tradeandotherpayablesundiscountedcashflows": 42473000,
    "bankborrowingsundiscountedcashflows": 1879000,
    "otherfinancialliabilitiesundiscountedcashflows": 165000,
    "bondsissuedundiscountedcashflows": 4250000,
    "derivativeandnonderivativefinancialliabilitiesundiscountedcashflows": 49841000,
    "liabilities": 165000,
    "financialassetsatfairvalue": 192963000,
    "financialliabilities": 140886000,
    "financialliabilitiesatfairvalue": 140886000,
    "undiscountedcontractualamountsdueincludingnominalinterest": 52077000,
    "liabilitiesarisingfromfinancingactivities": 140886000,
    "increasedecreasethroughobtainingorlosingcontrolofsubsidiariesorotherbusinessesliabilitiesarisingfromfinancingactivities": 14118000,
    "increasedecreasethroughamorisedcostsliabilitiesarisingfromfinancingactivities": 849000,
    "increasedecreasethroughchangesinfairvaluesliabilitiesarisingfromfinancingactivities": -27000,
    "increasedecreasethroughotherchangesliabilitiesarisingfromfinancingactivities": -11729000,
    "weightedaverageshares": 642007692,
    "adjustedweightedaverageshares": 701151525,
    "numberofsharesoutstandingdiluted": 648749282,
    "numberofconvertiblebondsoutstanding": 62412622,
    "numberofotherequityinstrumentsoutstandinginsharebasedpaymentarrangement": 10992546,
    "numberofsharesandotherinstrumentsoutstanding": 774943928,
    "numberofsharesauthorised": 880000000,
    "authorisedsharecapital": 10000000,
    "parvaluepershare": 0.01
  },
  {
    "date": "2020-12-31",
    "symbol": "PHAR",
    "period": "FY",
    "documenttype": "20-F",
    "documentregistrationstatement": "false",
    "documentannualreport": "true",
    "documentperiodenddate": "2020-12-31",
    "entityfilenumber": "001-39822",
    "currentfiscalyearenddate": "--12-31",
    "documenttransitionreport": "false",
    "documentshellcompanyreport": "false",
    "entityregistrantname": "Pharming Group N.V.",
    "entityincorporationstatecountrycode": "P7",
    "entityaddressaddressline1": "Darwinweg 24",
    "entityaddresspostalzipcode": "2333 CR",
    "entityaddresscityortown": "Leiden",
    "entityaddresscountry": "NL",
    "cityareacode": 908,
    "localphonenumber": "524 0888",
    "entityaddressstateorprovince": "NJ",
    "security12btitle": "American Depositary Shares, each representing ten ordinary shares, nominal value EUR 0.01 per share",
    "tradingsymbol": "PHAR",
    "securityexchangename": "NASDAQ",
    "entitycommonstocksharesoutstanding": 638821619,
    "entitywellknownseasonedissuer": "No",
    "entityvoluntaryfilers": "No",
    "entitycurrentreportingstatus": "Yes",
    "entityinteractivedatacurrent": "Yes",
    "entityfilercategory": "Non-accelerated Filer",
    "entityemerginggrowthcompany": "true",
    "icfrauditorattestationflag": "false",
    "entityextransitionperiod": "true",
    "documentaccountingstandard": "International Financial Reporting Standards",
    "entityshellcompany": "false",
    "entitycentralindexkey": 1828316,
    "documentfiscalyearfocus": 2020,
    "documentfiscalperiodfocus": "FY",
    "amendmentflag": "false",
    "contactpersonnelname": "Pharming Healthcare Inc.",
    "revenuefromcontractswithcustomers": 185694000,
    "costofsales": 20601000,
    "grossprofit": 165093000,
    "revenuefromgovernmentgrants": 1601000,
    "researchanddevelopmentexpense": 33712000,
    "generalandadministrativeexpense": 21079000,
    "salesandmarketingexpense": 45164000,
    "operatingexpenseexcludingcostofsales": 99955000,
    "profitlossfromoperatingactivities": 66739000,
    "gainslossesonchangeinfairvalueofderivatives": 60000,
    "otherfinanceincome": 626000,
    "otherfinancecost": 29151000,
    "financeincomecost": -28465000,
    "shareofprofitlossofassociatesandjointventuresaccountedforusingequitymethod": 317000,
    "profitlossbeforetax": 38591000,
    "incometaxexpensecontinuingoperations": 5556000,
    "profitloss": 33035000,
    "basicearningslosspershare": 0.051,
    "dilutedearningslosspershare": 0.048,
    "othercomprehensiveincomenetoftaxexchangedifferencesontranslation": -17000,
    "othercomprehensiveincomethatwillbereclassifiedtoprofitorlossnetoftax": -17000,
    "othercomprehensiveincome": -17000,
    "comprehensiveincome": 33018000,
    "intangibleassetsotherthangoodwill": 76615000,
    "propertyplantandequipment": 9956000,
    "rightofuseassets": 7676000,
    "deferredtaxliabilityasset": -25957000,
    "investmentsinassociatesaccountedforusingequitymethod": 5796000,
    "noncurrentrestrictedcashandcashequivalents": 415000,
    "noncurrentassets": 126415000,
    "inventories": 17229000,
    "tradeandothercurrentreceivables": 29236000,
    "currentrestrictedcashandcashequivalents": 810000,
    "cashandcashequivalents": 167068000,
    "currentassets": 214343000,
    "assets": 340758000,
    "issuedcapital": 6388000,
    "sharepremium": 396799000,
    "statutoryreserve": 4341000,
    "retainedearnings": -258151000,
    "equity": 149377000,
    "noncurrentportionofnoncurrentbondsissued": 121927000,
    "noncurrentleaseliabilities": 6702000,
    "othernoncurrentfinancialliabilities": 173000,
    "noncurrentliabilities": 128802000,
    "currentbondsissuedandcurrentportionofnoncurrentbondsissued": 1661000,
    "currentderivativefinancialliabilities": 147000,
    "tradeandothercurrentpayables": 38816000,
    "currentleaseliabilities": 1598000,
    "othercurrentfinancialliabilities": 20357000,
    "currentliabilities": 62579000,
    "equityandliabilities": 340758000,
    "numberofsharesoutstanding": 638821000,
    "increasedecreasethroughtransfertostatutoryreserve": 544000,
    "decreaseincreasethroughtaxonsharebasedpaymenttransactions": -2066000,
    "increasedecreasethroughsharebasedpaymenttransactions": 5721000,
    "numberofissuedduringtheperiodsharessettlementofbonuses": 34000,
    "increasedecreasethroughsharebasedpaymenttransactionsbonusequity": 45000,
    "increasedecreasethroughsharesissuedforcashandconversionofbondsequity": 1405000,
    "numberofwarrantsexercisedduringtheperiod": 60000,
    "increasedecreasethroughexerciseofwarrantsequity": 1000,
    "numberofshareoptionsexercisedinsharebasedpaymentarrangement": 7404000,
    "increasedecreasethroughexerciseofoptions": 74000,
    "transactionswithownersequitynumberofshares": 7498000,
    "increasedecreasethroughtransactionswithowners": 75000,
    "adjustmentsfordepreciationandamortisationexpenseandimpairmentlossreversalofimpairmentlossrecognisedinprofitorloss": 7276000,
    "adjustmentsforsharebasedpayments": 5721000,
    "adjustmentsforgainslossesonchangeinfairvalueofderivatives": 60000,
    "adjustmentsforfinanceincome": 624000,
    "adjustmentsforfinancecosts": 29151000,
    "adjustmentsforundistributedprofitsofinvestmentsaccountedforusingequitymethod": 317000,
    "otheradjustmentstoreconcileprofitloss": -1421000,
    "cashflowsfromusedinoperationsbeforechangesinworkingcapital": 78317000,
    "adjustmentsfordecreaseincreaseininventories": -2762000,
    "adjustmentsfordecreaseincreaseintradeandotherreceivables": -3499000,
    "adjustmentsforincreasedecreaseintradeandotherpayables": 2569000,
    "cashflowsfromusedindecreaseincreaseinrestrictedcashandcashequivalentsoperatingactivities": 1043000,
    "increasedecreaseinworkingcapital": 2649000,
    "interestreceivedclassifiedasoperatingactivities": 626000,
    "incometaxespaidrefundclassifiedasoperatingactivities": 2326000,
    "cashflowsfromusedinoperatingactivities": 73968000,
    "purchaseofpropertyplantandequipmentclassifiedasinvestingactivities": 4076000,
    "purchaseofintangibleassetsexcludinglicensesclassifiedasinvestingactivities": 7929000,
    "purchaseofinterestsininvestmentsaccountedforusingequitymethod": 288000,
    "purchaseofintangibleassetslicensesclassifiedasinvestingactivities": 1385000,
    "cashflowsfromusedininvestingactivities": -13678000,
    "repaymentsofborrowingsclassifiedasfinancingactivities": 50088000,
    "paymentsofcontingentconsiderationsclassifiedasfinancingactivities": 18136000,
    "paymentsofleaseliabilitiesclassifiedasfinancingactivities": 1913000,
    "proceedsfromissueofbondsnotesanddebentures": 125000000,
    "paymentsfordebtissuecosts": 2318000,
    "interestpaidclassifiedasfinancingactivities": 1875000,
    "proceedsfromissuingotherequityinstruments": 2443000,
    "cashflowsfromusedinfinancingactivities": 53113000,
    "increasedecreaseincashandcashequivalentsbeforeeffectofexchangeratechanges": 113403000,
    "effectofexchangeratechangesoncashandcashequivalents": -12634000,
    "closingforeignexchangerate": 1.228,
    "averageforeignexchangerate": 1.1426,
    "usefullifemeasuredasperiodoftimeintangibleassetsotherthangoodwill": "P2Y",
    "remainingamortisationperiodofintangibleassetsmaterialtoentity2019": "P16Y",
    "usefullifemeasuredasperiodoftimepropertyplantandequipment": "P20Y",
    "periodofservicebyemployeedefinedcontributionpension": "P6M",
    "employeeageeligiblefordefinedcontributionpension": "P18Y",
    "amountmatchedbyemployerdefinedcontributionpensionpercentage": 1,
    "employeecontributiondefinedcontributionpensionpercentage": 0.03,
    "vestingrequirementsforshareoptionsinsharebasedpaymentarrangementvestingperiod": "P5Y",
    "vestingrequirementsforsharebasedpaymentarrangementvestingperiod": "P3Y",
    "sharebasedpaymentarrangementserviceperiod": "P3Y",
    "performancerequirementsforsharebasedpaymentarrangementtotalshareholderreturnpercent": 0.4,
    "performancerequirementsforsharebasedpaymentarrangementlongtermstrategyorientedobjectivespercent": 0.6,
    "retentionrequirementforsharebasedpaymentarrangementretentionperiod": "P5Y",
    "proportionofownershipinterestinassociate": 0.4385,
    "liabilities": 20400000,
    "significantunobservableinputliabilities": 0.9,
    "leaseliabilities": 8300000,
    "percentageofentitysrevenue": 0.76,
    "costofsalesexcludinginventorywritedown": 20601000,
    "researchanddevelopmentemployeecosts": 18365000,
    "researchanddevelopmentamortizationcostsifa": 677000,
    "researchanddevelopmentdepreciation": 1805000,
    "researchanddevelopmentdirectoperatingexpenses": 11206000,
    "researchanddevelopmentotherindirectresearchanddevelopmentcosts": 1659000,
    "generalandadministrativeemployeecosts": 9817000,
    "generalandadministrativedepreciationppe": 1001000,
    "generalandadministrativedirectoperatingexpenses": 8355000,
    "generalandadministrativeotherindirectgeneralandadministrativeexpense": 1906000,
    "marketingandsalesemployeecosts": 20212000,
    "marketingandsalesamortisationcostsifa": 2834000,
    "marketingandsalesdepreciation": 757000,
    "marketingandsalesdirectoperatingexpenses": 20446000,
    "marketingandsalesotherindirectmarketingandsalescosts": 915000,
    "wagesandsalaries": 32217000,
    "socialsecuritycontributions": 3765000,
    "postemploymentbenefitexpensedefinedbenefitplans": 1614000,
    "expensefromsharebasedpaymenttransactionswithemployees": 7356000,
    "employeebenefitsexpense": 44952000,
    "depreciationandamortisationexpense": 1789000,
    "depreciationrightofuseassets": 1471000,
    "gainslossesrecognisedinprofitorlossfairvaluemeasurementliabilities": 60000,
    "borrowingsfeesincurredonloansettlement": 3775000,
    "currenttaxexpenseincome": 2367000,
    "adjustmentsforcurrenttaxofpriorperiod": -1310000,
    "currenttaxexpenseincomeandadjustmentsforcurrenttaxofpriorperiods": 1057000,
    "deferredtaxexpenseincomebeforeadjustments": 7535000,
    "adjustmentsfordeferredtaxofpriorperiods": -3036000,
    "deferredtaxexpenseincometotal": 4499000,
    "accountingprofit": 38591000,
    "taxexpenseincomeatapplicabletaxrate": 9647000,
    "taxeffectofforeigntaxrates": -233000,
    "taxeffectofrevenuesexemptfromtaxation2011": 256000,
    "taxeffectadjustmentsofpriorperiod": 1857000,
    "taxeffectfromchangeintaxrate": -2489000,
    "othertaxeffectsforreconciliationbetweenaccountingprofitandtaxexpenseincome": 744000,
    "deferredtaxassets": 27471000,
    "deferredtaxliabilities": 1514000,
    "deferredtaxexpenseincomerecognisedinprofitorloss": -1903000,
    "incometaxrelatingtocomponentsofothercomprehensiveincome": 230000,
    "deferredtaxrelatingtoitemschargedorcrediteddirectlytoequity": 2066000,
    "periodofforecasts": "P3Y",
    "netdeferredtaxassetscurrent": 8900000,
    "amortisationintangibleassetsotherthangoodwill": 44000,
    "additionsotherthanthroughbusinesscombinationsintangibleassetsotherthangoodwill": 139000,
    "acquisitionsthroughbusinesscombinationsintangibleassetsotherthangoodwill": 7500000,
    "changesinintangibleassetsotherthangoodwill": -44000,
    "periodoftransitionalservices": "P6M",
    "purchaseofintangibleassetsclassifiedasinvestingactivities": 1400000,
    "additionsotherthanthroughbusinesscombinationspropertyplantandequipment": 102000,
    "increasedecreasethroughtransferspropertyplantandequipment": -197000,
    "disposalspropertyplantandequipment": 49000,
    "depreciationpropertyplantandequipment": 298000,
    "depreciationpropertyplantandequipmentdisposals": 48000,
    "increasedecreasethroughnetexchangedifferencespropertyplantandequipment": 1000,
    "changesinpropertyplantandequipment": -393000,
    "depreciationexpense": 1800000,
    "additionstorightofuseassets": 3261000,
    "disposalsofrightofuseassets": 559000,
    "investmentinsubleaserightofuseassets": 363000,
    "depreciationrightofuseassetsdisposals": -70000,
    "increasedecreasethroughnetexchangedifferencesrightofuseassets": -49000,
    "increasedecreaseinrightofuseassets": 889000,
    "rentalexpense": 2444000,
    "leasesremainingleaseterm": "P1Y0M0D",
    "interestexpenseonleaseliabilities": 670000,
    "shareofprofitlossofassociatesaccountedforusingequitymethod": 316000,
    "investmentsaccountedforusingequitymethodfinancialguaranteeamortisation": -28000,
    "restrictedcashandcashequivalents": 1200000,
    "finishedgoods": 10376000,
    "workinprogress": 4616000,
    "rawmaterials": 2237000,
    "inventorywritedown2011": 1269000,
    "reversalofinventorywritedown": 1043000,
    "inventoryusageofwritedownprovision": 530000,
    "currenttradereceivables": 19149000,
    "currentprepayments": 3271000,
    "currentvalueaddedtaxreceivables": 1323000,
    "othercurrentreceivables": 1877000,
    "currentreceivablesfromtaxesandsocialsecurities": 3616000,
    "borrowings": 123588000,
    "bondsissuedinitialrecognitioncarryingvalue": 121277000,
    "borrowingcostsrecognisedasexpense": 650000,
    "interestexpenseonborrowingsnotyetpaid": 3536000,
    "currentborrowingsandcurrentportionofnoncurrentborrowings": 1661000,
    "longtermborrowings": 121927000,
    "borrowingsinterestrate": 0.03,
    "bondsissuedprincipalamountpercentageconvertedandrepurchasedandcancelled": 0.85,
    "borrowingsincreasedecreaseduetoreeavluation": 447000,
    "numberofwarrantsoutstanding": 148944,
    "increasethroughnewleasesliabilitiesarisingfromfinancingactivities": 3308000,
    "increasedecreasethroughinterestexpenseliabilitiesarisingfromfinancingactivities": 596000,
    "increasedecreasethroughfinancingcashflowsliabilitiesarisingfromfinancingactivities": -1913000,
    "grossleaseliabilities": 2109000,
    "financialliabilities": 147000,
    "changesinfairvalueoffinancialliabilityattributabletochangesincreditriskofliability": -60000,
    "increasedecreasefinancialliabilitiesatfairvaluethroughprofitorlossconversions": -61000,
    "tradeandothercurrentpayablestotradesuppliers": 10969000,
    "currentpayablesonsocialsecurityandtaxesotherthanincometax": 502000,
    "othercurrentpayables": 143000,
    "shorttermemployeebenefitsaccruals": 6607000,
    "accrualsrebatesanddiscountscurrent": 12158000,
    "accrualsproductioncostscurrent": 3353000,
    "accrualsothercurrent": 5084000,
    "numberofsharebasedpaymentarrangementplans": 2,
    "numberofinstrumentsotherequityinstrumentsgranted": 305000,
    "expensefromsharebasedpaymenttransactionsinwhichgoodsorservicesreceiveddidnotqualifyforrecognitionasassets": 7400000,
    "descriptionofoptionlifeshareoptionsgranted": 1,
    "descriptionofexpectedvolatilityshareoptionsgranted": 0.53,
    "descriptionofriskfreeinterestrateshareoptionsgranted": -0.0052,
    "weightedaverageexercisepriceofotherequityinstrumentsgrantedinsharebasedpaymentarrangement2019": 0.752,
    "numberofotherequityinstrumentsforfeitedinsharebasedpaymentarrangement": 20000,
    "numberofotherequityinstrumentsnotvestedinsharebasedpaymentarrangement": 46187,
    "numberofotherequityinstrumentsreservedinsharebasedpaymentarrangement": 238813,
    "numberofoutstandingshareoptions": 50106488,
    "numberofshareoptionsexpiredinsharebasedpaymentarrangement": 3281,
    "numberofshareoptionsgrantedinsharebasedpaymentarrangement": 15536750,
    "numberofshareoptionsforfeitedinsharebasedpaymentarrangement": 411250,
    "numberofshareoptionsvestedinsharebasedpaymentarrangement": 19675875,
    "numberofshareoptionsunvestedinsharebasedpaymentarrangement": 30430613,
    "weightedaverageexercisepriceofshareoptionsoutstandinginsharebasedpaymentarrangement2019": 0.74,
    "weightedaverageexercisepriceofshareoptionsexpiredinsharebasedpaymentarrangement2019": 0.294,
    "weightedaverageexercisepriceofshareoptionsexercisedinsharebasedpaymentarrangement2019": 0.443,
    "weightedaverageexercisepriceofshareoptionsgrantedinsharebasedpaymentarrangement2019": 0.974,
    "weightedaverageexercisepriceofshareoptionsforfeitedinsharebasedpaymentarrangement2019": 0.521,
    "weightedaverageexercisepriceofshareoptionsvestedinsharebasedpaymentarrangement": 0.583,
    "weightedaverageexercisepriceofshareoptionsunvestedinsharebasedpaymentarrangement": 0.842,
    "exercisepriceofoutstandingshareoptions2019": 0.063,
    "exercisevalueofshareoptionsoutstandinginsharebasedpaymentarrangement": 674000,
    "exercisepriceshareoptionsgranted2019": 0.201,
    "keymanagementpersonnelcompensationbasesalary": 538000,
    "keymanagementpersonnelbonus": 377000,
    "keymanagementpersonnelcompensationsharebasedpayment": 1522000,
    "keymanagementpersonnelcompensationpostemploymentbenefits": 94000,
    "keymanagementpersonnelcompensationother": 32000,
    "keymanagementpersonnelcompensation": 2563000,
    "keymanagementpersonnelcompensationterminationbenefits": 306000,
    "numberofsharesinentityheldbyrelatedparties": 6638869,
    "sharesreservedforissueunderoptionsandcontractsforsaleofshares": 118531119,
    "directorsremunerationexpensebasesalary": 65000,
    "directorsremunerationexpenseauditcommitteeexpense": 3000,
    "directorsremunerationexpenserenumerationcommittee": 6000,
    "directorsremunerationexpenseextraordinary": 3000,
    "directorsremunerationexpensesharebasedpayment": 52000,
    "directorsremunerationexpense": 117000,
    "purchasesofgoodsrelatedpartytransactions": 2600000,
    "servicefeespayablerelatedpartytransactions": 100000,
    "keymanagementpersonnelcompensationshorttermemployeebenefits": 2359000,
    "otherfinancialliabilities": 20530000,
    "contingentconsiderationperioddue": "P1Y",
    "contractualcapitalcommitments": 17800000,
    "cashandcashequivalentsandrestrictedcashandcashequivalents": 168300000,
    "cash": 10100000,
    "cashandcashequivalentsrestrictedcashaccountsreceivableandinventories": 216500000,
    "balancesdenominatedinforeigncurrency": 189400000,
    "sensitivityanalysisimpactoftenpercentstrengtheningofforeigncurrencyagainsttheeuro": 15400000,
    "sensitivityanalysisimpactoftenpercentweakeningofforeigncurrencyagainsttheeuro": -15400000,
    "tradeandotherpayablesundiscountedcashflows": 38816000,
    "derivativefinancialliabilitiesundiscountedcashflows": 147000,
    "bankborrowingsundiscountedcashflows": 1661000,
    "otherfinancialliabilitiesundiscountedcashflows": 20530000,
    "bondsissuedundiscountedcashflows": 3750000,
    "derivativeandnonderivativefinancialliabilitiesundiscountedcashflows": 65352000,
    "financialassets": 168293000,
    "financialassetsatfairvalue": 168293000,
    "financialliabilitiesatfairvalue": 123588000,
    "undiscountedcontractualamountsdueincludingnominalinterest": 43480000,
    "liabilitiesarisingfromfinancingactivities": 123588000,
    "increasedecreasethroughobtainingorlosingcontrolofsubsidiariesorotherbusinessesliabilitiesarisingfromfinancingactivities": 3308000,
    "increasedecreasethroughamorisedcostsliabilitiesarisingfromfinancingactivities": 449000,
    "increasedecreasethroughchangesinfairvaluesliabilitiesarisingfromfinancingactivities": 3249000,
    "increasedecreasethroughotherchangesliabilitiesarisingfromfinancingactivities": 3703000,
    "weightedaverageshares": 636268929,
    "adjustedweightedaverageshares": 682737280,
    "profitlossattributabletoordinaryequityholdersofparententityincludingdilutiveeffects": 33000000,
    "averagenumberofordinarysharesasunderlyingforconvertiblebonds": 60702687,
    "numberofconvertiblebondsoutstanding": 62412622,
    "numberofotherequityinstrumentsoutstandinginsharebasedpaymentarrangement": 9979208,
    "numberofsharesandotherinstrumentsoutstanding": 761468881,
    "numberofsharesauthorised": 880000000,
    "numberofsharesoutstandingdiluted": 638821619,
    "authorisedsharecapital": 8800000,
    "parvaluepershare": 0.01
  }
]